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This doctoral thesis has been elaborated at the Department of Biochemical 
Sciences of the Faculty of Pharmacy in Hradec Králové, Charles University, in the 
research team of professor Dršata. The team has been engaged in the non-enzymatic 
glycation of enzymes in various in vitro models *Beránek et al. 2001, Dršata et al. 2002] 
and also in the possibilities to slow down this process by naturally occurring 
substances [Boušová et al. 2005a, Boušová et al. 2009] for many years. 
Dietary plant polyphenols are naturally occurring substances with various 
biological and pharmacological activities in living organism. However, many 
mechanisms of their actions have not been fully elucidated yet. It seems that the 
interaction between polyphenols and biological macromolecules may play a role 
during these actions. A great significance possesses the interactions of plant 
polyphenols with serum albumin which acts as a carrier of various endogenous and 
exogenous low molecular compounds in blood stream. One of the main goals of this 
thesis was to study structure-binding affinity relationships between serum albumin 
and two selected groups of polyphenolic compounds such as hydroxycinnamic acids 
and catechins (flavanols) in the in vitro models using spectroscopic (UV-Vis absorption 
and fluorescence spectroscopy) and electrophoretic (native and SDS PAGE) methods. 
Green tea catechins were selected as representatives of the most outstanding plant 
polyphenols with a broad spectrum of beneficial biological and pharmacological 
properties. Their potential inhibitory effects on methylglyoxal-mediated non-
enzymatic glycation of serum albumin in the in vitro models have been investigated by 
fluorescence methods and their structure-activity relationships are discussed. 
Moreover, effects of methylglyoxal as a very potent glycating agent on structural 
and catalytic properties of recombinant cytosolic glutathion S-transferase from 
Schistosoma japonicum in the in vitro model have been investigated by spectroscopic 
(UV-Vis absorption and fluorescence spectroscopy) and electrophoretic (native PAGE, 
SDS PAGE/western blotting) methods. 
A part of the results of this thesis has been obtained at the Department of 
Biochemical Sciences „A. Rossi Fanelli“ of Sapienza University of Rome in the research 
team of professor Altieri in the frame of Lifelong Learning programme - Erasmus. 
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Effects of green tea catechins on catalytic and structural properties of ERp57 enzyme 
have been investigated and their structure-activity relationships are discussed. 
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2 GENERAL INTRODUCTION 
 
2.1 PROTEIN STRUCTURE AS A PREREQUISITE FOR THEIR PROPER FUNCTION 
Proteins are the most abundant and functionally diverse biological 
macromolecules in living organisms. Most proteins spontaneously fold to a unique 
three dimensional “native” conformation, which is a prerequisite for their proper 
function (e.g. transport, enzymatic activity). Failure to assume this structure has often 
various catastrophic consequences for the cell metabolism (e.g. Creutzfeldt-Jakob 
disease [Herges et al. 2002]). Moreover, this native conformation can be reversibly or 
irreversibly changed or disrupted by various processes such as non-covalent or 
covalent modifications, denaturation, peptide bond cleavage [Berg et al. 2002]. 
Particular examples can be non-covalent or covalent protein modifications during their 
interaction with plant polyphenols or covalent process of non-enzymatic protein 
glycation due to reducing sugars or reactive α-dicarbonyl compounds. 
 
 
2.2 PROTEIN OXIDATION AS AN IMPORTANT FACTOR OF THEIR DAMAGE 
 
2.2.1 Pro-oxidants and oxidative stress 
Living organisms are constantly exposed to many different systems (Figure 1), 
which generate reactive oxygen and nitrogen species (RONS) as very effective pro-
oxidants. These systems include environmental factors, such as irradiation (e.g. X-rays, 
γ-rays, UV light) and pollutants in the atmosphere (e.g. ozone, NO2, cigarette smoke) 
[Kelly 2004, Schröder and Krutmann 2005], and many of them are by-products of 
normal metabolic processes such as autoxidation of reduced forms of electron carriers 
(e.g. NAD(P)H, reduced flavins, cytochrome P450s), inflammatory reactions, nitric 
oxide synthesis, oxidase-catalyzed reactions, lipid peroxidation, glycation/glycoxidation 







Figure 1: The sources and cellular responses to reactive oxygen and nitrogen 
species [Finkel and Holbrook 2000].  
 
Free radicals are molecules or molecular fragments containing one or more 
unpaired electrons in their outer valance shell. Reactive oxygen and nitrogen species 
is a general term for both free radicals (e.g. O2
-•, HO•, or NO•) and their reactive non-
radical metabolites without unpaired electron(s) (e.g. H2O2, ONOO
-) [Halliwell and 
Gutteridge 1998]. The examples of RONS with their biological life-times are stated in 
Table 1. RONS and their metabolites are usually very unstable and reactive particles. 
They are able to promptly react with various biological structures such as fatty acids 
and lipids, amino acids and proteins, mono- and polynucleotides (nucleic acids), low-






Table 1: Reactive oxygen and nitrogen species with their biological life-times. 
Modified according to Štípek et al. [2000].  
 
REACTIVE OXYGEN SPECIES (ROS) 
Free radicals Non-radicals 
superoxide anion, O2
-• (2-4 μs) hydrogen peroxide, H2O2 (1 ms) 
hydroxyl radical, OH-• (1-10 ns) hypochlorous acid, HClO 
peroxyl radical, ROO• (7 s) ozone, O3 
alkoxyl radical, RO• (1 ns) singlet oxygen, 1O2 
hydroperoxyl radical, HO2• (> 1 s)  
REACTIVE NITROGEN SPECIES (RNS) 
Free radicals Non-radicals 
nitric oxide, NO• (1-10 s) nitrosyl, NO+ 
nitrogen dioxide, NO2• nitrous acid, HNO2 
 peroxonitrite, OONO- (1s) 
 
The transition metals are able due to their variable oxidation number to catalyze 
both redox reactions necessary for physiological functions and undesirable free radical 
reactions in vivo [Halliwell and Gutteridge 1998]. Generally, hydrogen peroxide and 
alkyl peroxides are the most common end products of most pro-oxidant systems. 
These peroxides themselves are relatively un-reactive compounds. However, in the 
presence of the transition metals such as Fe(II) or Cu(I), they are converted to the 
highly reactive hydroxyl (HO•) or alkoxyl (RO•) radicals, which immediately attack 
important biomolecules. 
RONS and their reactive metabolites can play a double role in the organism, a 
positive and a negative one. Under certain circumstances they are required for the 
proper physiological functions of some systems (e.g. important inter-mediators of 
energy transfer, immunity defense factors, and signal molecules of cell regulation), but 
on the other hand, if they are produced in large quantities, they can become harmful 
to the organism and are able to damage or even kill organism [Dröge 2002, Ďuráčková 
2010, Pan et al. 2009]. Generally, in healthy organism there exists a balance between 
the production and manifestation of RONS and other reactive metabolites, and a 
biological system's ability to readily detoxify the reactive intermediates or to repair the 
resulting oxidative damage. The condition when this fragile balance is disrupted is 
called oxidative stress [Halliwell and Gutteridge 1998]. This imbalance can be caused 
by an excessive generation of RONS, an insufficient activity of the antioxidant 
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protection systems, or a failure to repair oxidative damage. The oxidative stress is a 
very complicated and complex process and its impact on the organism depends on the 
type of pro-oxidant, on the site and intensity of its production, on the composition and 
activities of various antioxidants, and on the ability of repair systems. It can lead either 
to cellular adaption (i.e. up-regulation of the defense systems), to issue injury (e.g. 
serious oxidation damage of important biomolecules, loss of physiological function, 
pathological accumulation of oxidized products in cells), or to cell death caused by 
apoptosis or necrosis [Halliwell and Gutteridge 1998, Stadtman 2004]. At present, the 
opinion that oxidative stress is not always harmful has been accepted. However, it is 
not exactly known where a border between their physiological and pathological effect 
is, what that effect depends on, and how a shift to one or to the other side can be 
influenced *Ďuráčková 2010+. 
The oxidative stress has been implicated in the pathological development of many 
human age-related disorders and diseases. It is well known that it is not always the 
main cause of the disease but usually occurs as a consequence of previous tissue 
damage (e.g. infection, toxins, trauma). Among diseases which significantly contribute 
to oxidative impairment range atherosclerosis and cardiovascular diseases [Elahi et al. 
2009, Kondo et al. 2009], neurodegenerative diseases such as Parkinson’s and 
Alzheimer’s diseases [Gella and Durany 2009, Jomova et al. 2010], diabetes and 
metabolic syndrome [Cohen and Tong 2010, Whaley-Connell et al. 2011], chronic 
inflammatory diseases [Ferguson 2010], carcinogenesis [Klaunig et al. 2010, Pan et al. 
2009] and many others. Oxidative stress plays an important role also in the 
physiological process of aging [Drew and Leeuwenburgh 2002, Romano et al. 2010, 
Stadtman 2004].  
To fight excessive production of RONS and their reactive metabolites, the 
organism has evolved protective systems and mechanisms against their toxic effects. 
Protection of the organism is organized at three levels. First of them includes systems 
preventing RONS formation, such as inhibitors of enzymes catalyzing RONS formation 
(e.g. allopurinol inhibits xanthine oxidase producing superoxide), or trapping of 
transition metal ions by chelating agents and thus elimination of their catalytic activity 
during production of RONS. When these primary protective systems are insufficient 
and RONS have already been formed, scavengers and trappers of RONS come into 
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action and eliminate the high reactivity of RONS by turning them into inactive and non-
toxic metabolites. These compounds are called antioxidants, which prevent oxidation 
of biologically important molecules by RONS. If protection of the organism fails at this 
level, then repair systems recognize impaired molecules and decompose them, as it is 
in case of proteinases at oxidatively modified proteins, lipases at oxidatively damaged 
lipids, or DNA repair systems at modified DNA bases [Halliwell and Gutteridge 1998, 
Štípek et al. 2000+. 
It is well known that some high and low molecular weight endogenous and 
exogenous compounds act as antioxidants. High molecular weight antioxidants 
include the enzymes (e.g. superoxide dismutase, glutathione peroxidase, glutathione 
transferase, catalase) and non-enzymatic antioxidants involve proteins, which are able 
to bind transition metals (e.g. transferrin, lactoferrin, ceruloplasmin, albumin) and thus 
suppress their possibility to catalyze unwanted free radical reactions. Recently, a large 
attention has been focused also on the function of so-called chaperones whose 
synthesis is induced by oxidative stress. They are probably able to recognize the 
oxidized proteins, bind them and accelerate their elimination in proteosomes. They 
participate also in protein conformation reparation (e.g. ERp57). Low molecular 
weight antioxidants comprise hydrophilic and lipophilic compounds produced either 
endogenously in the organism (e.g. uric acid, lipoic acid, glutathione, ubiquinol as 
reduced co-enzyme Q) or they are obtained from diet as exogenous antioxidants (e.g. 
vitamin C, vitamin E, plant polyphenolic compounds including hydroxycinnamic acids 
and flavonoids) [Ďuráčková 2010, Halliwell and Gutteridge 1998, Štípek 2000]. It is very 
important to note that antioxidants do not possess only beneficial effects. Under 
certain circumstances they can act as pro-oxidants and thus can participate in tissue 
impairments and consequently in development of diseases *Procházková 2011+. 
 
2.2.2 Protein oxidation 
Protein oxidation is posttranslational process which is implicated in the 
physiological process of ageing [Romano et al. 2010] and the development of many 
pathological age-related diseases [Cohen and Tong 2010, Elahi et al. 2009, Lyons 1995, 
Martínez et al. 2010]. RONS and their metabolites can lead to oxidation of the protein 
backbone resulting in protein fragmentation, oxidation of amino acid residue side 
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chains, and formation of protein-protein cross-linkages [Stadtman and Levine 2003]. 
These oxidatively modified proteins are not mostly repaired and must be removed 
from organism by proteolytic degradation. Decrease in the efficiency of proteolysis will 
cause their accumulation in the cellular content which can lead to disruption of cellular 
functions either by loss of catalytic and structural integrity or by interruption of 
regulatory pathways [Stadtman and Levine 2000]. Extent of oxidative modified 
proteins in cells reflects the balance between the pro-oxidant and antioxidant activities 
of the organism and is dictated by prevailing environmental, genetic, and dietary 
factors [Stadtman 2004]. Oxidation also takes place during non-enzymatic protein 
glycation that is described in the following chapter. 
 
2.2.3 Non-enzymatic glycation as a complex process of protein damage 
Non-enzymatic glycation, also known as Maillard reaction, was first described in 
1912 by Louis Camille Maillard and it had been extensively studied by food chemists 
[Monnier 1989]. Much later, around 1980s, it was recognized that also proteins in 
human body are modified by non-enzymatic glycation leading to the onset and 
progression of many human diseases, such as diabetes mellitus and its related 
complications, atherosclerosis, Alzheimer´s disease, and a process of aging [Nursten 
2005]. Plenty of in vitro and in vivo studies have been devoted to non-enzymatic 
glycation process with respect to investigation of protein structural and functional 
changes [Seidler and Kowalewski 2003, Zhao et al. 2000, Zeng et al. 2006] and to 
finding suitable therapeutic intervention to the glycation process [Martini et al. 2010, 
Stuchbury and Münch 2005]. 
 
2.2.3.1 Term and individual steps of glycation process 
Non-enzymatic protein glycation is a covalent modification involving several 
steps. Firstly, free amino groups of proteins react slowly with the carbonyl groups of 
reducing sugars (e.g. glucose, fructose, galactose) or certain related compounds (e.g. 
α-oxoaldehydes, ascorbic acid) to yield acid-labile Shiff base intermediates (early 
glycated products) that undergo rearrangement to produce relatively stable 
derivatives known as Amadori or Heyns products (intermediate glycated products) in 
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the case of aldose (e.g. glucose) or ketose (e.g. fructose), respectively (Figure 2) 
*Janebová et al. 1999, Schalkwijk et al. 2004+. 
 
 
Figure 2: Non-enzymatic glycation between protein free amino groups and glucose or 
fructose [Schalkwijk et al. 2004]. 
 
The intermediate glycated products are either directly converted into irreversible 
advanced glycation end products (AGEs) or more often together with Schiff bases 
degraded into compounds known as α-dicarbonyls or α-oxoaldehydes (e.g. glyoxal, 
methylglyoxal, 3-deoxyglucosone) (Figure 3) that are more reactive than the parent 
sugars [Yim et al. 2001]. In addition, carbonyl compounds can be generated during 
metal-catalyzed autoxidation of glucose. During this process, hydrogen peroxide and 
free radicals are also formed and they are able to initiate other oxidative steps. The 
glycation process accompanied by oxidation steps is termed glycoxidation [Baynes et 
al. 1991, Hunt et al. 1988, West 2000, Wolff and Dean 1987]. Possibilities of AGEs 




glyoxal (GO) methylglyoxal (MGO) 3-deoxyglucosone (3-DG) 






Figure 4: Glucose and AGEs formation pathways including the polyol pathway and 
AGE formation by the α-oxoaldehydes [Singh et al. 2001]. 
 
Non-enzymatic glycation has been decribed in long-lived proteins such as lens 
crystallins, collagen, elastin, and myelin [Cervantes-Laurean et al. 2006, Winlove et al. 
1996, Zhao et al. 1996] as well as short-lived proteins (e.g. serum albumin [Suarez et al. 
1989, Vetter and Indurthi 2011, Westwood and Thornalley 1995], hemoglobin [Bae 
and Lee 2004, Lee et al. 2011], histones [Gugliucci et al. 2009], ovoalbumin [Zeng et al. 
2006]) and enzymes (e.g. catalase [Yan and Harding 1997, Zhao et al. 2000], alanine 
aminotransferase [Beránek et al. 2001], aspartate aminotransferase [Boušová et al. 
2005b, Seidler and Seibel 2000], glutathione reductase [Blankytny and Harding 1992], 
superoxide dismutase [Yan and Harding 1997, Zhao et al. 2000]). 
 
2.2.3.2 Glycating agents 
In general, reducing sugars (e.g. glucose, fructose, galactose, mannose, ribose), 
their metabolites (e.g. α-oxoaldehydes), and also certain other carbohydrate relatives 
(e.g. ascorbic acid) are reactive toward nucleophiles such as free amino groups of 
proteins, lipids, or nucleic acids. In fact, glucose is the least reactive among the 
common sugars, perhaps leading to its evolutionary selection as the principal sugar in 
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vivo [Bunn et al. 1978]. Due to its low reactivity towards proteins, AGEs have been 
thought to be formed only at long-lived extracellular proteins, such as collagen, 
crystallines, elastin, and myelin [Cervantes-Laurean et al. 2006, Winlove et al. 1996, 
Zhao et al. 1996]. However, also rapid intracellular AGE formation by various 
intracellular sugars and their metabolites (e.g. fructose, ribose, glyceraldehyde, 
glyceraldehyde-3-phosphate, glyoxal, methylglyoxal, 3-deoxyglucosone) in vivo has 
been described [Nursten 2005, Schalkwijk et al. 2004, Yan and Harding 1997, Zeng et 
al. 2006]. For example, the rate of glycation of fructose, glyceraldehyde-3-phosphate, 
and methylglyoxal is 7.5-fold, 200-fold, and 10,000-fold faster in comparison with 
equimolar amount of glucose, respectively [Beisswenger et al. 2003, Boušová et al. 
2011, Schalkwijk et al. 2004]. 
Alpha-dicarbonyl compounds, formed in vivo during glycation or basal 
metabolism (e.g. β-oxidation of fatty acids), are very potent glycating agents. These 
compounds are thought to be principal agents in generation of inter- and intra-
molecular cross-links which are responsible for irreversible changes in proteins and can 
induce oxidative stress and cell apoptosis [Nass et al. 2007, Yim et al. 2001]. Excessive 
generation of α-dicarbonyls can lead to their accumulation in human body and it is 
called carbonyl stress [Miyata et al. 1998]. 
 
2.2.3.3 Advanced glycation end products 
The advanced glycation end products (AGEs) represent a heterogeneous group of 
compounds rising from different precursors. Their chemical structures have not been 
fully described yet. They are formed endogenously inside as well as outside of cells 
during the last stage of glycation process either by oxidative (e.g CML, pentosidine) or 
non-oxidative (e.g. pyrraline, imidazolone) pathways or by reaction between α-
dicarbonyl compounds and protein free amino groups (e.g. CEL, CML, GOLD, MOLD, 
pyrraline) (Figure 4) [Singh et al. 2001, Ulrich and Cerami 2001]. Proteins modified by 
non-enzymatic glycation show significant changes in their physical-chemical properties 
such as a considerable increase in molecular weight, a yellow-brown pigmentation, a 
typical fluorescent spectra (e.g. excitation 370 nm and emission 440 nm), an ability of 
aggregation and cross-links formation, an increase in biological half-life, a change in 
solubility and protein charge, a decrease in isoelectric point, a resistance against 
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proteolytic degradation and denaturation, and an easy chemical hydrolysis *Janebová 
et al. 1999, Nass et al. 2007]. 
The advanced glycation end products formed under physiological conditions are 
often classified according to their fluorescent properties and to their ability to form 
cross-links (Figure 5). The first group includes fluorescent AGE cross-links, such as 
pentosidine, crossline, and various vesperlysines, which are probably responsible for a 
majority of the harmful effects of AGEs in diabetes and ageing. Fluorescence is a good 
qualitative indicator used to estimate of AGEs formation. However, also non-
fluorescent AGE cross-links, such as glucosepan and imidazolium dilysines (e.g. GOLD, 
MOLD) are found in vivo. They account only for 1% of all cross-links and their isolation 
and identification is more complicated. The third group represents non-cross-linking 
protein bound AGEs, such as arpyrimidine, pyrraline, imidazolones, and 
carboxyalkyllysines (e.g. CML and CEL). They may possess deleterious effects as 
precursors of cross-links or as biological receptor ligands inducing a variety of adverse 
cellular and tissue changes [Ahmed 2005, Ulrich and Cerami  2001]. 
 








































Figure 5: Classification and structures of AGEs formed under physiological conditions 
[Ulrich and Cerami 2001]. 
 
 The AGEs can be degraded into AGE peptides by macrophages or T-lymphocytes 
through their specific scavenger receptors located on cell surfaces. These peptides are 
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subsequently released and excreted by kidney [Vlassara 1997]. Serum level of AGE 
peptides well correlates with renal function. If their level is decreased and they are not 
excreted by kidney, they covalently react with proteins and form so-called second 
generation of AGE proteins *Janebová et al. 1999+. However, the AGE modified 
proteins can induce oxidative stress by their binding to AGE specific cellular receptors. 
For example, a receptor for AGE (RAGE) is expressed by various cell systems such as 
smooth muscle cells, T lymphocytes, monocytes, macrophages, microglia, endothelial, 
and mesangial cells [Ahmed 2005]. Interaction of AGEs with RAGE on macrophages 
causes oxidative stress and activation of transcription nuclear factor NF-κB, which 
induces production of cytokines and tissue growth factors [Lapolla et al. 2005, Singh et 
al. 2001]. AGE-R3, also called galectin-3, expressed on macrophages represents 
another protein receptor with high affinity for AGE that promotes high molecular 
weight complexes formation after the binding of AGE. It is associated with 
development of several tumours [Mercer et al. 2004, Nass et al. 2007]. 
 
2.2.3.4 Consequences of glycation and importance in human pathology 
The AGE modifications influence the structural as well as the functional properties 
of proteins. It has been shown that the presence of an AGE modification alters activity 
of several enzymes [Ahmed and Thornalley 2005, Boušová et al. 2011, Zeng and Davies 
2005]. The excessive formation of AGEs and their accumulation in tissues possesses a 
wide range of harmful effects on human body such as direct structural damage, 
changes in physical properties and metabolism of extracellular matrix, or indirect 
induction of oxidative stress by their binding to AGE specific receptors on cell surfaces 
(e.g. RAGE) *Janebová et al. 1999, Nass et al. 2007, Sato et al. 2006a+. It consequently 
contributes to the onset and progression of many human diseases, such as diabetes 
mellitus and its related complications, atherosclerosis, neurodegenerative diseases 
(e.g. Alzheimer´s diseases), and a process of ageing [Ahmed 2005, Nass et al. 2007, 
Nursten 2005, Yegin et al. 1995]. The glycation process, also known as glycoxidation, is 
closely connected with oxidative stress. During the AGE formation, the reactive oxygen 
species (ROS) are abundantly generated and consequently significantly contribute to 
glycation. Glycoxidation reactions are usually catalyzed by transition metal ions 
[Baynes 1999, West 2000].  
23 
 
Diabetes mellitus (DM) is a metabolic disorder with high prevalence in human 
population which is characterized by increased level of glucose in blood 
(hyperglycaemia) and its excretion by urine. There are mainly two types of diabetes 
mellitus – Type 1 and Type 2. In Type 1 DM (insulin-dependent diabetes mellitus, 
IDDM), in the absence of pancreatic β-cells the insulin is not produced. Type 2 DM 
(non-insulin-dependent diabetes mellitus, NIDDM, T2DM) is characterized by a 
progressive impairment of insulin secretion by  pancreatic β-cells  and by a relative 
decreased in sensitivity of target tissues to the action of this hormone *Štípek et al. 
2000]. This disease is always accompanied by oxidative stress [Giacco and Brownlee 
2010]. Diabetes without proper treatment can caused many complications. Acute 
complications include for example hypoglycaemia, diabetic ketoacidosis, or non-
ketonic hyperosmolar coma. Serious long-term complications involve cardiovascular 
diseases, chronic renal failure, and retinal damage. Thus adequate treatment of DM is 
important as well as blood pressure control, levels of glycated hemoglobin (HbA1c) 
control, and lifestyle factors such as smoking cessation and maintaining a healthy body 
weight [Nass et al. 2007]. 
 Hyperglycaemia is regarded as the primary cause of diabetic microvascular 
complications such as retinopathy, nephropathy, and neuropathy. Diabetic 
retinopathy affects blood vessel formation in the retina of the eye. It can lead to 
reduced vision or potentially blindness [Durham and Herman 2011, Glenn and Stitt 
2009]. Diabetic nephropathy can lead to scarring changes in the kidney tissue, loss of 
small or progressively large amount of protein in the urine, and eventually chronic 
kidney diseases requiring dialysis [Nursten 2005, Yamagishi and Matsui 2010]. Diabetic 
neuropathy possesses the impact on the nervous system which most commonly causes 
numbness, tingling, and pain in the feet. Together with vascular disease in the legs, 
neuropathy contributes to the risk of diabetes related foot problems such as diabetic 
foot ulcers connected with necrosis and gangrene formation leading to amputation 
[Ahmed 2005, Pinzur 2011]. 
Hyperglycaemia is also a contributing factor to diabetic macrovascular disease. It 
significantly accelerates atherosclerosis of large arteries and leads to ischemic heart 
disease (angina pectoris and myocardial infarction), stroke and peripheral vascular 
disease [Giacco and Brownlee 2010, Katwal and Dokun 2011, Yegin et al. 1995]. 
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 Also in the course of physiological process of ageing, increasing amounts of AGEs 
can be detected in many tissues with a further increase in patients with diabetes [Nass 
et al. 2007]. AGEs accumulate without any diseases just by age. The age-related 
accumulation of AGEs was shown in human cartilage, skin collagen and pericardial fluid 
[Dyer et al. 1992, Simm et al. 2007, Verzijl et al. 2000]. Recent studies have also 
revealed that Type 2 diabetes mellitus, which progressively increases with age, is a risk 
factor for neurodegenerative diseases, especially those related to Alzheimer’s disease 
[Ristow 2004, Sato et al. 2006b]. 
 
2.2.3.5 Therapeutic strategies targeting the AGEs 
As the AGEs are believed to contribute to the development of major diseases, 
several strategies have been developed to avoid AGE formation or to break present 
AGE cross-links. The therapeutic intervention leading to decrease of AGE formation has 
followed three main approaches. First approach is inhibition of AGE formation by 
carbonyl-blocking agents or by antioxidants. Aminoguanidine (Pimagedine), a 
prototype therapeutic agent, is a low-molecular nucleophilic hydrazine compound, 
which is able to rapidly react with α-dicarbonyls to prevent formation of AGE cross-
links [Abdel-Rahman and Bolton 2002]. However, its side effects in clinical treatment 
of diabetic nephropathy appeared [Bolton et al. 2004, Thornalley 2003]. Other 
nucleophilic compounds, which were designed to trap reactive carbonyl intermediates 
generated during AGE formation, are for example OPB-9195, metformin, or 
pyridoxamine [Booth et al. 1996, Sztanke and Pasternak 2003, Yamagishi et al. 2008]. 
Also compounds with antioxidant ability, such as scavengers of free radicals and 
chelators of transition metal ions, were tested. These antioxidants include e.g. α-lipoic 
acid, α-tocopherol, ascorbic acid, β-carotene, dipeptide carnosine, antioxidant 
enzymes (e.g. SOD, CAT), or flavonoids [Golbidi 2011, Nicolle et al. 2011, Rahimi et al. 
2005]. The second approach represents reducing AGE deposition using cross-link 
breakers (e.g. phenyl thiazolium bromide (PTB), alagebrium chloride (ALT-711)) or by 
enhancing cellular uptake and degradation [Vasan et al. 1996, Willemsen et al. 2010, 
Yamagishi et al. 2008]. The last approach involves inhibition of RAGE by neutralizing 
antibodies or suppression of post-receptor signaling using antioxidants [Hudson et al. 




2.2.3.6 Methods suitable for monitoring of glycation process 
Due to the complexity of non-enzymatic glycation process, no universal method 
exists for its powerful monitoring and assessment. Various techniques and methods 
based on different methodological approaches can be used for this intention. Each of 
them provides different information and possesses its advantages as well as 
disadvantages. Choice of methods depends on the intended purposes of monitoring. 
Sometimes, their combinations have been used for better understanding of the non-
enzymatic glycation process and thus finding of convenient strategy for its suppression 
[Gugliucci et al. 2009, Tsuji-Naito et al. 2009]. 
One of the possibilities for monitoring of glycation process is application of 
methods which study changes in structural and catalytic properties of proteins. They 
involve for example spectroscopic (UV-Vis absorption, fluorescence, circular dichroism, 
FTIR) or electrophoretic (native PAGE, SDS PAGE/western blotting) methods suitable 
for investigation of protein changes in their spectral characteristics, molecular weight, 
charge, or solubility [Ahmad et al. 2007, Gugliucci et al. 2009, Mikulíková et al. 2005, 
Peng et al. 2008, Schmitt et al. 2005, Wu et al. 2009]. Moreover, in the case of 
enzymes, study of the changes in their catalytic activity is applied as the most 
characteristic feature of enzyme molecules [Beránek et al. 2001, Boušová et al. 2009]. 
Powerful approach for monitoring of glycation process includes identification and 
quantification of arising AGEs mostly by immunochemical, spectrofluorimetric, or 
chromatographic methods. The immunochemical methods are based on antigenic 
properties of AGEs. The total amount of individual AGEs (e.g. pentosidine, CML, 
pyrraline) can be determined by enzyme-linked immunosorbent assay (ELISA) with 
specific polyclonal or monoclonal antibody marked by enzyme [Ghanem et al. 2011, 
Izuhara et al. 1999, Jono et al. 2004, Nagai et al. 2008, Taneda and Monnier 1994]. 
Several commercial enzyme immunoassay kits for rapid detection and quantification of 
AGE protein adducts in biological fluids have been developed. Some cross-linked and 
non-cross-linked AGEs possess characteristic fluorescence spectra (e.g. λex/λem: 
370/440 nm or 330/410 nm for total amount of AGEs, 335/385 nm for pentosidine, 
320/380 nm for argpyrimidine), which can be applied as a good indicator for their 
detection and quantification [Tsuji-Naito et al. 2009, Wu and Yen 2005] primarily in the 
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combination with appropriate separation techniques such as high performance liquid 
chromatography (HPLC). In general, chromatographic methods, especially HPLC and 
gas chromatography (GC), with specific fluorescent (FLD) or mass spectrometric (MS) 
detection, are highly accurate and sensitive methods that are widely applied for 
separation, identification and quantification of metabolic intermediates (e.g. α-
oxoaldehydes) and individual AGEs in biological samples. For instance, HPLC with 
photometric (diode array detection, DAD) or fluorescent (FLD) detection with or 
without appropriate derivatization can be applied for determination of glyoxal, 
methylglyoxal, or 3-deoxyglucosone [Dhar et al. 2009, Espinosa-Mansilla et al. 2007, 
Thornalley et al. 1999], and individual AGEs such as pyrraline [Portero-Otin et al. 1995], 
N-ε-carboxymethyllysine (CML) [Ghanem et al. 2011, Mikulíková et al. 2005], 
pentosidine [Ghanem et al. 2011, Mikulíková et al. 2008, Scheijen et al. 2009] or 
argpyrimidine [Wilker et al. 2001]. Pentosidine and CML are used as good biomarkers 
of glycoxidation and oxidative stress, respectively [Moreira et al. 2005, Sell et al. 1991]. 
High performance liquid chromatography with mass spectrometry (HPLC-MS, HPLC-
MS/MS) represents highly powerful technique for quantification of individual AGEs, 
e.g. CEL, CML, argpyrimidine, or pentosidine [Mikulíková et al. 2007, Srey et al. 2010, 
Zhang et al. 2011, Zmatlíková et al. 2010]. Also gas chromatography with mass 
spectrometry (GC-MS) is employed for determination of glyoxal, methyglyoxal [Lapolla 
et al. 2003, Wu et al. 2008], or 3-deoxyglucosone [Niwa 1999, Wu et al. 2008], and 
individual AGEs such as CEL or CML [Cantero et al. 2007, Petrovic 2005]. In addition, 
other sophisticated tehniques can be also applied for these purposes such as capillary 
(zone) electrophoresis [Mikulíková et al. 2007, Zmatlíková et al. 2010] or matrix-
assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) 
[Barnaby et al. 2011, Frost et al. 2011]. 
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2.3 ROLE OF PLANT POLYPHENOLS IN PROTEIN PROTECTION FROM OXIDATIVE 
DAMAGE 
As has been mentioned above, one of the possibilities of protein protection 
against oxidative damage including non-enzymatic glycation/glycoxidation is the intake 
of naturally occurring compounds with antioxidant activities such as plant polyphenols 
which can protect proteins using various mechanisms (e.g. trapping of ROS or reactive 
α-dicarbonyl species, chelating of transition metal ions) [Gugliucci et al. 2009, Sang et 
al. 2007]. On the other hand, these compounds can act also as pro-oxidants under 
certain conditions and thus can contribute to protein oxidation and protein non-
enzymatic glycation [Lambert JD and Elias 2010, Procházková et al. 2011]. The exact 
action of plant polyphenols in human organism has not been fully elucidated. It seems 
to be more complex process and other investigations need to be carried out. 
Plant polyphenols represent a heterogeneous group of natural compounds with 
one or more aromatic and/or heterocyclic rings bearing one or more hydroxyl and/or 
methoxyl substituents. These secondary plant metabolites formed by the shikimate 
pathway are widely distributed in higher plants as glycosides or aglycons. The most 
common bound sugars are glucose, galactose, rhamnose, arabinose, xylose, and 
rutinose. Polyphenols possess several important physiological roles in plants, such as 
defense against herbivores and pathogens, pigmentation, and attraction of pollinating 
insects [Dewick 2002, Pietta 2000]. They are a part of the human diet and a great 
interest in these substances has been motivated by the potential health benefits 
arising from their antioxidant activity [Galleano et al. 2010, Rice-Evans et al. 1996]. 
These substances are widely used in Chinese folk medicine due to their biological and 
pharmacological properties. However, several negative effects have been also 
described [Kaku and Nakagawa 2009, Lambert and Elias 2010]. The major groups of 
plant polyphenols include flavonoids, hydroxycinnamic acids, phenolic acids, lignans, 
and tannins.   
 
2.3.1 Hydroxycinnamic acids 
Hydroxycinnamic acids (HCAs) are widely distributed polyphenolic compounds in 
plant tissues (Table 2). Some of the most common naturally occurring HCAs are p-
coumaric, caffeic, ferulic, and sinapic acids. These compounds can be found in a free 
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form but more often in various conjugated forms resulting from enzymatic 
hydroxylation, O-glycosylation, O-methylation or esterification [Harborne and Williams 
2000, Rice-Evans et al. 1997]. Hydroxycinnamic acids have been reported to possess 
antimicrobial, antiallergic and anti-inflammatory activities, as well as antimutagenic 
and immunomodulatory effects [Natarajan et al. 1996, Pannala et al. 1998]. They have 
also significant antioxidant and anti-radical activities [Croft 1998, Graf 1992, Natella et 
al. 1999, Rice-Evans et al. 1996]. Moreover, anti-glycating effects of several HCAs (e.g. 
chlorogenic acid) on non-enzymatic glycation of serum albumin by glucose and 
methylglyoxal have been described [Gugliucci et al. 2009, Kim et al. 2011, Wang et al. 
2009]. The biological effects of HCAs are strongly dependent on their structures, 
namely the presence of aromatic rings and number and position of hydroxyl groups 
[Rice-Evans et al. 1996]. Just these structural features suggest their possibility of 
binding with proteins and thus they can alter the biophysical and biochemical 
properties of protein [Kang et al. 2004, Min et al. 2004]. 
 
Table 2: Structures of cinnamic acid and its hydroxyderivatives. 
 
R1 R2 R3 R4 R5 Compunds 
H H H H H Cinnamic acid 
OH H H H H o-Coumaric acid 
H OH H H H m-Coumaric acid 
H H OH H H p-Coumaric acid 
H OH OH H H Caffeic acid 
H OCH3 OH H H Ferulic acid 



































2.3.2 Flavonoids including green tea catechins 
Flavonoids, a group of benzo-γ-pyron derivatives, are a major group of plant 
polyphenolic secondary metabolites widely distributed in the human diet occurring 
especially in fruits, vegetables, and some beverages (e.g. beer, wine, tea, coffee, fruit 
drinks) [Pietta 2000, Rice-Evans et al. 1996]. Over 9,000 individual compounds have 
been identified so far. Despite this huge diversity, all flavonoids can be recognized by 
their structural properties. Their structure is based on the flavonoid nucleus (flavan) 
(Figure 6) which consists of two aromatic rings (A and B rings) linked by an oxygen-
containing heterocyclic ring (C ring). The major flavonoid subclasses comprise flavones, 
isoflavones, flavanones, flavonols, flavanols (catechins), and anthocyanidines. These 
subclasses differ in the level of oxidation and patern of substitution of the C ring, while 
individual compounds within a subclass vary in the pattern of substitution of the A and 
B rings. Substitutions include hydrogenation, hydroxylation, methylation, 
malonylation, sulfation, and glycosylation. Many flavonoids occur naturally as 
flavonoid glycosides including e.g. glucose, rhamnose, galactose, or rutinose as sugar 
component [Rice-Evans et al. 1997]. The subclasses of flavonoids with their best 
known representatives are given in Table 3.  
Flavonoids exert a broad spectrum of multiple biological activities and important 
therapeutic applications including for example antioxidant, anti-inflammatory, 
antimicrobial, antiviral, antimutagenic, anticancer, cardioprotective, neuroprotective, 
antidiabetic, estrogenic/antiestrogenic, and antiallergic properties [Bastianetto et al. 
2009, Cabrera et al. 2006, Clere et al. 2011, Croft 1998, Harbone and Williams 2000, 
Hwang 2012, Kawai et al. 2007, Nicole et al. 2011, Pietta 2000, Rathee et al. 2009, Yang 
et al. 2009]. However, several harmful effects of flavonoids involving for example pro-
oxidant or cytotoxic activity have been already demostrated [Dickancaité et al. 1998, 
Lambert and Elias 2010, Procházková et al. 2011, Schmalhausen et al. 2007]. Many 
biologically active flavonoids appear to have effects on various proteins including 
enzymes such as xantine oxidase or glyceraldehyde-3-phosphate dehydrogenase 
[Harbone and Williams 2000, Schmalhausen et al. 2007]. The flavonoids possess 
suitable structural features, namely the aromatic rings and hydroxyl groups, which 
suggest their posibility of binding with molecules of proteins including enzymes. 
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Therefore, they are believed to affect the biophysical and biochemical properties of 
proteins.  
 
Figure 6: Generic structure of flavonoid (flavan). 
 




R1 R2 R3 R4 R5 R6 Flavone 
OH H OH H H H Chrysin 
OH OH OH H H H Baicalein 
OH H OH H H OH Apigenin 
OH H OH H OH OH Luteolin 
OH H OH H OH OCH3 Diosmetin 
OH H OH OCH3 H H Wogonin 
OH OCH3 OH OCH3 H OCH3 Nevadensin 
OH OH OGlc H H H Baicalin 
OH H ONeO H H OH Rhoifolin 
OH H ORut H H OH Isorhoifolin 




R1 R2 R3 R4 Isoflavone 
H H OH OH Daidzein 
OH H OH OH Genistein 
OH H OH OCH3 Biochanin 
H OCH3 OH OH Glycitein 
H H OGlc OH Daidzin 
OH H OGlc OH Genistin 









R1 R2 R3 R4 Flavanone 
OH OH H H Pinocembrin 
OH OH H OH Naringenin 
OH OH OH OH Eridiktyol 
OCH3 OH H H Alpinetin 
OH OH OH OCH3 Hesperetin 
OH OGlc H OH Pruning 
OH ORut H OH Narirutin 
OH ORut H OCH3 Didymin 
OH ORut OH OH Eriocitrin 
OH ORut OH OCH3 Hesperidin 
OH ONeo H OH Naringin 
OH ONeo H OCH3 Poncirin 
OH ONeo OH OH Neoeriocitrin 
FLAVONOLS 
 
R1 R2 R3 R4 R5 R6 R7 Flavanols 
OH H OH OH H OH H Morin 
OH OH OH H H OH H Kaempferol 
OH OH OH H OH OH H Quercetin 
OH OH OH H OH OH OH Myricetin 
OH OH OH H H OCH3 H Kemferid 
OH OH OCH3 H OH OH H Rhamnetin 
OH OH OH H OCH3 OH H Isorhamnetin 
OGlc OH OH H H OH H Astragalin 
OGlc OH OH H OH OH H Isoquercitrin 
ORha OH OH H OH OH H Quercitrin 
OGal OH OH H OH OH H Hyperosid 
ORut OH OH H OH OH H Rutin 
ANTHOCYANIDINES 
 
R1 R2 R3 R4 R5 Anthocyanidine 
OH OH H OH H Pelargonidin 
OH OH OH OH H Kyanidin 
OH OH OH OH OH Delfinidin 
OH OH OCH3 OH H Peonidin 
OH OH OCH3 OH OH Petunidin 





   
(+)-Catechin (-)-Catechin (-)-Epicatechin 
R1 R2 Flavanols 
H H (+)-Catechin, (-)-Catechin, (-)-Epicatechin 
OH H (+)-Gallocatechin, (-)-Gallocatechin, (-)-Epigallocatechin 
H 
 
(-)-Catechin gallate, (-)-Epicatechin gallate 
OH 
 
(-)-Gallocatechin gallate, (-)-Epigallocatechin gallate 
Gal (galactose), Glc (glucose), Neo (neohesperidose), Rha (rhamnose), Rut (rutinose) 
 
 
2.3.2.1 Green tea catechins 
Green tea (Camellia sinensis, Theaceae), one of the most consumed beverages in 
the world, is rich source of polyphenols, mainly catechins (flavan-3-ols) so-called green 
tea catechins (GTCs). The major GTCs, which account for 30-40% of its dry weight, are 
epicatechin (6.4%), epicatechin gallate (13.6%), epigallocatechin (19.0%), and the most 
important epigallocatechin gallate (59.0%) [Singh et al. 2010]. They possess a broad 
spectrum of promoting biological activities such as antioxidant, anti-inflamantory, 
antimicrobial, and antiviral properties [Cabrera et al. 2006, Friedman 2007, Lambert 
and Elias 2010, Pastore and Fratellone 2006, Rice-Evans et al. 1997, Song and Seong 
2007, Yang et al. 2009] and significantly contribute to the beneficial health effects of 
green tea in the prevention and treatment of various diseases such as cancer, heart 
diseases, diabetes, neurodegenerative disease, and metabolic syndrome [Cabrera et al. 
2006, Crespy and Williamson 2004, Hodgson and Croft 2011, Khan and Mukhtar 2007, 
Lambert and Elias 2010, Sharangi 2009, Stote and Baer 2008, Thielecke and 
Boschmann 2009, Velayutham et al. 2008]. On the other hand, several negative 
activities of catechins such as pro-oxidative, cyto- and phytotoxic properties have been 
already described [Kaku and Nakagawa 2009, Lambert and Elias 2010, Lu et al. 2011]. 
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Green tea and green tea catechins, mainly epigallocatechin gallate, have attracted a 
great interest among researches for several decades. Even though various in vitro and 
in vivo studies have been carried out, there are still many questions and unclearness. 
In general, catechins  comprise diphenyl propane skeleton (flavone backbone) 
where a polyphenolic ring (A) is condensed with six-membered oxygen containing 
heterocyclic ring (C) that carries another phenolic ring (B) at the 2 position (Table 3). 
Green tea catechins differ in number of hydroxyl groups and the presence or absence 
of the galloyl moiety at the 3 position. Their structures as well as structures of other 
low-molecular weight drugs suggest the possibilities of binding affinity to proteins (e.g. 
serum albumin [Maiti et al. 2006]), enzymes (e.g. glyceraldehyde-3-phosphate 
dehydrogenase [Ishii et al. 2008]), and other targets (e.g. lipids, [Sun et al. 2009], cell 
surface [Fujimura et al. 2008]), which can be realized by reversible non-covalent [Diniz 
et al. 2008, Frazier et al. 2006, Maiti et al. 2006, Nozaki et al. 2009, Papadopoulou et 
al. 2005, Soares et al. 2007] or irreversible covalent interactions [Ishii et al. 2008, 
Tanaka et al. 2011] depending on environmental conditions (e.g. presence of oxygen, 
pH, hydrophobicity), type of target, and structure and disposition of drugs. The studies 
dealing with interaction of catechins with serum albumin [Ishii e al. 2010a, Maiti et al. 
2006], lipids bilayers [Hashimoto et al. 1999, Sun et al. 2009], or cell surface [Fujimura 
et al. 2008] showed that their binding affinity depends on structural features of 
individual catechins, mainly on the presence of the galloyl moiety, number of hydroxyl 
groups and the spatial arrangement of molecule. Moreover, anti-glycating effect of 
some catechins and green tea resulting apparently from their trapping activity of 
reactive oxygen and reactive carbonyl species has been already noticed [Lunceford and 
Gugliucci 2005, Jang et al. 2009, Wu and Yen 2005]. 
 
2.3.3 Polyphenol-protein interactions 
In last two decades, a considerable attention has been focused on the study of 
interaction between low-molecular ligands (drugs) and biological macromolecules (e.g. 
proteins), especially discussing the thermodynamic quality, binding force quality, and 
mechanism of interactions. The drug-protein interactions can have the both positive 
and negative impacts on living organisms. For instance, it is well known that reversible 
binding of drugs to serum albumin is a key factor for their deposition, transportation, 
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metabolism, and thus efficacy in body [Carter and Ho 1994, Peters 1996]. In contrast, 
drugs can cause various irreversible changes in protein/enzyme conformation 
influencing its physiological functions [Ishii et al. 2008]. Generally, these studies play a 
crucial role in promoting research on proteins because they can provide useful 
information for study of pharmacological and biological effects of drugs and 
conformational changes of proteins caused by drugs [Otagiri 2005].  
Dietary polyphenolic compounds such as hydroxycinnamic acids and flavonoids 
have received much attention owing to their biological properties and are considered 
as nutraceuticals. Polyphenols react readily with various proteins and enzymes by 
mostly non-specific way to form non-covalent [Prigent et al. 2003] or covalent [Ishii et 
al. 2008] complexes in dependence on their chemical structures, concentration of 
protein and polyphenols, and ambient conditions (e.g. pH, presence of oxidizing agent, 
temperature). Moreover, polyphenols can be converted into reactive intermediates 
which can form irreversible covalent bonds with nucleophiles of proteins such as thiol 
groups. In general, the hydrophobicity, presence or absence of some functional 
groups, steric hindrance, and spatial arrangement seem to be the key factors in the 
affinity of natural occurring polyphenols towards proteins [Diniz et al. 2008, Ishii et al. 
2010a].   
Research dealing with interactions between plant polyphenols and plasma 
proteins as carriers of numerous endogenous and exogenous compounds (e.g. serum 
albumin, hemoglobin, α-acid glycoprotein, α-amylase) [Diniz et al. 2008, Soares et al. 
2007] possesses a great importance in pharmacology, pharmacodynamics, and 
biochemistry. The binding affinity of polyphenols towards plasma proteins, especially 
serum albumin, is believed to modulate their bioavailability and to be closely related to 
their biological function [Kusuda et al. 2006, Otagiri 2005]. One of the most used 
model proteins is serum albumin and a wide range of the studies concerning with 
serum albumin-polyphenol interactions have been carried out. These interactions 
suggest that binding of polyphenols with serum albumin is stabilized by hydrophobic 
interactions, hydrogen-bonding forces, and electrostatic forces [Minoda et al. 2010]. 
Moreover, serum albumin possesses also antioxidant properties and thus can prevent 





2.3.3.1 Techniques used for assessment of ligand-protein interactions 
In general, a wide range of techniques and methods have been developed for the 
study of ligand-protein interactions. Each of them provides different information about 
the character of interactions and binding parameters. Based on the procedures of 
mixture separation of the bound and free ligand, equilibrium dialysis and ultrafiltration 
followed by the sophisticated techniques such as high performance liquid 
chromatography (HPLC) or capillary electrophoresis (CE) had been commonly used to 
determine unbound ligand concentrations both in vitro and in vivo samples [Li et al. 
2002, Zargar and Rabbani 2002]. However, the potential problems are that relatively 
large quantities of ligand are required and that the equilibrium between bound and 
unbound ligand may shift during the experiment. Moreover, these methods require 
expensive instruments and skilled operators. Surface plasmon resonance (SPR) [Zhang 
et al. 2007], affinity capillary electrophoresis (ACE) [Zhang et al. 2007], and sodium 
dodecyl sulphate (SDS) or native polyacrylamide gel electrophoresis (PAGE) [Kusuda et 
al. 2006] are other techniques, which have been applied for the studies of ligand-
protein interactions.  
Spectroscopic techniques such as UV-Vis absorption spectroscopy [Kanakis et al. 
2006, Zhang et al. 2009], fluorescence spectroscopy [Liu et al. 2010, Sentchouk and 
Bondaryuk 2007], circular dichroism spectroscopy (CD) [Nozaki e al. 2009, He et al. 
2005], and attenuated total reflectance-Fourier transform infrared spectroscopy (FTIR) 
[Tian et al. 2005, Xie et al. 2006] can be used to investigation of ligand-protein 
interactions because of their sensitivity, rapidity and ease of implementation. One of 
the most important attributes of these techniques is that they are equilibrium 
methods, which do not need any previous separation procedures that may disturb the 
equilibrium state of the sample solutions. They are ideal tools to observe 
conformational changes in protein structure since allow non-destructive 
measurements of substances at low concentration under physiological conditions. The 






2.3.3.1.1 UV-Vis absorption spectroscopy 
Generally, UV-Vis absorption measurement is a very simple but effective method 
to explore the structural changes and the complex formation. Proteins show 
characteristic UV spectrum with maximum wavelength about 280 nm due to the 
presence of aromatic amino acids, especially tryptophan and tyrosine. Several 
approaches dealing with study of ligand-protein interactions by UV-Vis absorption 
spectroscopy have been applied including direct comparison of spectra (protein versus 
ligand-protein) [Zhang et al. 2009], determination of binding constant by spectroscopic 
titration [Kanakis et al. 2006, Zsila et al. 2003] or a second derivative 
spectrophotometric method [Omran et al. 2011]. 
 
2.3.3.1.2 Fluorescence spectroscopy 
Fluorescence spectroscopy is a powerful method to study molecular interactions 
involving proteins caused by the intrinsic protein fluorescence, which originates with 
the presence of aromatic amino acids. In proteins, the dominant fluorescent group is 
the indole nucleus of tryptophan residue that absorbs and emits near 295 nm and 340 
nm, respectively. The emission of tryptophan is highly sensitive to its local 
environment (e.g. solvent polarity), and is often used as a reporter group for protein 
conformational changes. Spectral shifts of protein emission have been observed as a 
result of several phenomena, including binding of ligands, protein-protein association, 
and protein unfolding. The emission of tryptophan indole group may shift to shorter 
wavelengths (blue shift) if this group becomes more buried within a native protein 
(folded), and its emission may shift to longer wavelengths (red shift) when the protein 
is unfolded [Lakowicz 2006, Vivian and Callis 2001].  
One of the most applied spectroscopic methods used for the studies of molecular 
interactions between proteins and low-molecular weight ligands is fluorescence 
quenching methods. Fluorescence quenching is the decrease of the quantum yield of 
fluorescence from a fluorophore induced by a variety of molecular interactions with 
quencher molecule such as excited-state reactions, molecular rearrangements, energy 
transfer, ground-state complex formation (static quenching), and collisional (dynamic) 
quenching. Dynamic (collisional) quenching occurs when the excited-state fluorophore 
is deactivated upon contact with some other molecule (quencher), and no molecule is 
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chemically altered during this process. In the case of static quenching, a non-
fluorescent complex is formed between molecules of fluorophore and quencher. The 
static and dynamic quenching can be distinguished by the Stern-Volmer analysis.  
Dynamic quenching of fluorescence is described by the well-known Stern-Volmer 
equation: 
F0/F = 1 + KSV[Q] = 1 + Kqτ0[Q] (1) 
 
In this equation, F0 and F are the fluorescence intensities of protein in the absence and 
presence of the quencher, respectively. [Q] is the quencher (low-molecular ligand) 
concentration, KSV is the Stern-Volmer quenching constant (KSV = Kqτ0), Kq is the 
bimolecular quenching rate constant (Kq = KSVτ0
-1), and τ0 is the lifetime of the 
fluorophore in the absence of the quencher. The value of τ0 is about 5.10
-9 s for serum 
albumin [Lakowicz 2006]. In the case, the Stern-Volmer plot (F0/F versus [Q]) shows 
linear dependence, the quenching is either purely static or dynamic, whereas when the 
plot shows exponential dependence, both static and dynamic quenching is asserted 
[Lakowicz 2006]. 
The dynamic quenching depends on diffusion, while static quenching does not. 
One criterion for distinguishing the type of quenchinq is the fact that the bimolecular 
quenching constant kq is larger than the limiting diffusion rate constant of the 
biomolecule (2.0 x 1010 l.mol-1.s-1), so the dynamic quenching is not the main reason 
that causes fluorescence quenching of protein, and the static quenching process can 
be postulated to obtain the binding parameters [Lakowicz 2006]. 
Binding parameters such as binding constants and number of binding sites can be 
obtained using one of these following logarithmic equations [Bi et al. 2005]. 
 
log(F0 - F)/F) = logKb + nlog[Q] (2) 
  
log(F0 – F)/F = nlogKb – nlog(1/([Qt] - (F0 – F)[Pt]/F0)) (3) 
 
where Kb represents the binding constant for quencher-protein interaction, n is the 
number of binding sites per protein, F0 and F are the fluorescence intensities before 
and after the addition of the quencher, [Qt] and [Pt] are the total quencher 
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concentration and the total protein concentration, respectively. The values of Kb and n 
could be thus obtained from the intercept and slope by plotting log (F0 – F)/F against 
log [Q] or nlog(1/([Qt] - (F0 – F)[Pt]/F0)).  
Utilizing Kb, the free energy change (∆G
0) value can be estimated from the 
following equation and the negative sing of its value confirms the spontaneity of 
binding [Shang et al. 2006]. 
∆G0 = -RTlnKb (4) 
 
2.3.3.1.3 Fluorescence resonance energy transfer 
Fluorescence resonance energy transfer (FRET) is a distance-dependent 
interaction in which the excitation energy is transferred non-radiatively from the 
donor molecule (protein) to the acceptor molecule (ligand). The efficiency of energy 
transfer can be used to evaluate the distance between the ligand and the tryptophan 
residues in the protein. According to Förster´s non-radiative energy transfer theory 
[Förster and Sinanoglu 1966], the efficiency of the energy transfer depends on: (a) the 
extent of overlap between the emission spectrum of the donor and the absorption 
spectrum of the acceptor, (b) the orientation of the transition dipole of the donor and 
the acceptor, and (c) the distance between the donor and the acceptor [Lakowicz 
2006]. The efficiency of energy transfer (E) between the donor and the acceptor is 
given by: 





where F0 and F are the fluorescence intensities of protein in the absence and presence 
of ligand, r0 is the distance between donor and acceptor, and R0 is the critical distance 
when the transfer efficiency is 50%. The value of R0
6 can be calculated using the 
equation: 
R0
6 = 8.8 x 10-25 k2N-4 Ф J (6) 
 
where k2 is the spatial orientation factor describing the relative orientation in space of 
the transition dipoles of the donor and the acceptor, N is the refractive index for the 
medium, Ф is the fluorescence quantum yield of the donor in the absence of the 
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acceptor, and J is the overlap integral of the emission spectrum of the donor and 
acceptor absorption spectrum (cm3 l mol-1). J is given by: 
 
J = ΣF(λ)ε(λ)λ4Δλ/ ΣF(λ)Δλ (7) 
 
where F(λ) is the fluorescence intensity of the donor at wavelength λ, ε(λ) is the molar 
absorption coefficient of the acceptor at wavelength λ to λ + Δλ (cm-1 mol-1 l). 
Finally, the distance between donor and acceptor (r0) is calculated using equation 
(5). In the case, it is lower than 8 nm and the condition 0.5R0 < r0 < 1.5R0 is fulfilled it 
indicates that non-radiation energy transfer from donor to acceptor occurred with high 
probability [Lakowicz 2006, Guo et al. 2009]. 
 
2.3.3.1.4 Polyacrylamide gel electrophoresis 
Sodium dodecyl sulfate (SDS) and native polyacrylamide gel electrophoresis 
(PAGE) can be used for the analysis of the formation of water-soluble complexes from 
combinations of various polyphenolic compounds and plasma proteins (e.g. serum 
albumin). SDS PAGE is commonly used to estimate the molecular size of a protein. 
Samples for SDS PAGE analysis are generally denaturated by a treatment with sodium 
dodecyl sulfate (SDS), mercaptoethanol, and by heating. In contrast, native PAGE does 
not involve denaturation and the shape and charge of the protein is altered after the 
complex formation which is demonstrated by the changes in its mobility. Coupling of 
SDS PAGE with western blotting can significantly increase the sensitivity of this 
method [Ishii et al. 2011, Minoda et al. 2010].  
Several formations of macromolecular complexes and changes in electrophoretic 
mobility of proteins were confirmed for some polyphenol-serum albumin systems 
[Kusuda et al. 2006, Minoda et al. 2010, Rawel et al. 2002]. Research has revealed that 
the polyphenol behavior during complexation with proteins depends on the 
polyphenol structure and used experimental conditions [Minoda et al. 2010]. The 
oxidation of polyphenols may contribute to the formation of more stable 
macromolecular complexes as has been described for epigallocatechin gallate-BSA 
system [Kusuda et al. 2006]. 
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2.3.3.2 Examples of plant polyphenol-serum albumin interactions 
Several studies dealing with the interaction of serum albumin with cinnamic acid 
and its hydroxyderivatives such as p-coumaric, caffeic, ferulic, sinapic, and chlorogenic 
acids have been carried out (Table 4). Different spectroscopic (e.g. UV-Vis absorption 
spectroscopy, fluorescence quenching, FRET, circular dichroism, FTIR) and non-
spectroscopic (e.g. capillary electrophoresis, calorimetry, surface plasmon resonance, 
ultracentrifugation) methods were applied for evaluation of the interaction character, 
determination of the binding and thermodynamic parameters, and discussion 
concerning the binding affinity-structure relationships. One of the most outstanding 
and studied hydroxycinnamic acids is surely chlorogenic acid (ester of caffeic and 
quinic acid) (Table 4) and its derivatives [Singh and Mitra 2011, Tang et al. 2008a]. The 
relationships between the structure of seven naturally occurring HCAs and their 
binding affinities towards BSA are discussed in chapter 5.1. 
 
Table 4: Examples of in vitro studies of HCA-serum albumin interactions. 
 
Hydroxycinnamic acid Protein Applied techniques  References 
Caffeic aid BSA UV-Vis absorption, 
fluorescence, 
equilibrium dialysis 
[Adzet et al. 1988, 
Bartolomé et al. 2000, Li 
et al. 2010] 
HSA fluorescence, FTIR [Min et al. 2004] 
Chlorogenic acid BSA UV-Vis absorption, 





[Li et al. 2010, Prigent et 
al. 2003, Rawel et al. 
2002, Seifert et al. 2004, 
Tang et al. 2008a, Wang 
et al. 2011, Yang et al. 
1994] 





[Diniz et al. 2008, Hu et 
al. 2012, Kang et al. 
2004, Muralidhara and 
Prakash 1995, Wang et 
al. 2010a, Yang et al. 
1994] 
Cinnamic acid BSA fluorescence, FRET, 
FTIR, CD 
[Bian et al. 2007] 
HSA fluorescence, FTIR  [Min et al. 2004] 
p-Coumaric acid HSA fluorescence, FTIR [Min et al. 2004] 
Ferulic acid BSA UV-Vis absorption, 
affinity capillary 
electrophoresis, SPR 




HSA fluorescence, FRET, 
FTIR 
[Kang et al. 2004] 
Sinapic acid HSA fluorescence, FTIR [Liu et al. 2005] 
CD (circular dichroism), FRET (fluorescence resonance energy transfer), FTIR (Fourier transform infrared 
specroscopy), NMR (nuclear magnetic resonance), SDS PAGE (sodium dodecyl sulfate polyacrylamide gel 
electrophoresis), SPR (surface plasmon resonance) 
 
Studies of interactions between flavonoids and plasma proteins, especially serum 
albumin, have attracted a great attention in research community. It is caused by their 
biological and pharmacological activities which seem to be related to the formation of 
their complexes with proteins [Kusuda et al. 2006]. Various techniques and methods 
can be applied for study of flavonoid-serum albumin interactions including non-
spectroscopic (e.g. calorimetry, capillary electrophoresis, equilibrium dialysis, size-
exclusion chromatography, SDS and native PAGE) and spectroscopic (e.g. UV-Vis 
absorption and fluorescence spectroscopy, circular dichroism, FTIR) methods (Table 5). 
Catechins, also known as flavanols, are one of the most outstanding groups of 
flavonoids with a wide range of beneficial activities on human organism. The 
assessment of the relationships between eight naturally occurring catechins and their 
binding affinities towards human serum albumin is discussed in detail in chapter 5.2.  
 
Table 5: Examples of in vitro studies of flavonoid-serum albumin interactions. 
 
Flavones Protein Applied techniques References 
Apigenin BSA fluorescence  [Cao et al. 2008] 
HSA  UV-Vis absorption, CD, 
fluorescence, capillary 
electrophoresis 
[Diniz et al. 2008, Xiao et 
al. 2010a, Yuan et al. 
2007] 
Baicalein BSA fluorescence  [Cao et al. 2008, Xiao et 
al. 2010b, Xiao et al. 
2009] 
HSA  fluorescence  [Xiao et al. 2010b] 
Baicalin BSA fluorescence  [Xiao et al. 2009] 
HSA  fluorescence, FRET [Bi et al. 2004] 
Chrysin BSA UV-Vis absorption, CD, 
fluorescence, FRET 
[Xiao et al. 2010b, Zhang 
et al. 2009] 
HSA  fluorescence  [Xiao et al. 2010b] 
Diosmetin BSA, HSA  fluorescence  [Dufour and Dangles 
2005] 
Flavone BSA fluorescence  [Xiao et al. 2010b] 
HSA  capillary [Diniz et al. 2008, Xiao et 
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electrophoresis al. 2010b] 
3-Hydroxyflavone BSA fluorescence, 
fluorescence 
anisotropy 
[Guharay et al. 2001] 
7-Hydroxyflavone BSA fluorescence  [Xiao et al. 2010b] 
HSA  UV-Vis absorption, 
fluorescence, CD 
[Banerjee et al. 2008, Xiao 
et al. 2010b] 
Luteolin BSA UV-Vis absorption, CD, 
fluorescence 
[Dufour and Dangles 
2005, Shi et al. 2011, 
Zhang et al. 2011b] 





[Dufour and Dangles 
2005, Jurasekova et al. 
2009, Xiao et al. 2010a] 
Nevadensin BSA fluorescence, FRET, CD [Yu et al. 2008] 
HSA  UV-Vis absorption, 
fluorescence, FRET, 
molecular modeling 
[Li et al. 2007a] 
Vicenin-2 HSA  capillary 
electrophoresis 
[Diniz et al. 2008] 
Vitexin HSA  capillary 
electrophoresis 
[Diniz et al. 2008] 
Wogonin BSA fluorescence, CD, FTIR [Tian et al. 2005] 
HSA  fluorescence 
spectroscopy, CD, FTIR 
[Tian et al. 2004a] 
Isoflavones Protein Applied techniques References 
Calycosin BSA UV-Vis absorption, 
fluorescence 
[Liu et al. 2010] 
Daidzein BSA fluorescence  [Bolli et al. 2010] 
HSA  CD, FTIR, fluorescence 
anisotropy, molecular 
modeling 
[Li et al. 2007b, Mahesha 
et al. 2006] 
Daidzin BSA fluorescence  [Xiao et al. 2009, Zhao 
and Ren 2009] 
Genistein BSA fluorescence  [Bolli et al. 2010, Cao et 
al. 2008, Xiao et al. 2009] 
HSA  fluorescence, 
equilibrium dialysis, CD, 
molecular modeling 
[Mahesha et al. 2006] 
Genistin BSA fluorescence  [Xiao et al. 2009, Zhao 
and Ren 2009] 
Irisflorentin  BSA UV-Vis absorption, 
fluorescence, FRET 
[Zhang et al. 2008a] 
Puerarin BSA fluorescence  [Xiao et al. 2009] 
HSA  fluorescence, CD, FTIR, [Li et al. 2008] 
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Sophoricoside HSA   UV-Vis absorption, 
fluorescence, FTIR, 
molecular modeling 
[Tang et al. 2008b] 
Flavanones Protein Applied techniques References 
Alpinetin BSA UV-Vis absorption, 
fluorescence, FTIR 
[Ni et al. 2010, Zhang et 
al. 2010] 




[He et al. 2005] 
Flavanone HSA  capillary 
electrophoresis 
[Diniz et al. 2008] 
Hesperetin BSA UV-Vis absorption, 
fluorescence, CD, FTIR 
[Hegde et al. 2011] 
HSA  UV-Vis absorption, 
FTIR, fluorescence 
[Xie et al. 2005] 
Naringenin BSA fluorescence  [Bolli et al. 2010, Dufour 
and Dangles 2005] 
Flavonols Protein Applied techniques References 
Fisetin BSA fluorescence  [Sentchouk and 
Bondaryuk 2007] 
Galangin BSA fluorescence  [Cao et al. 2008, Xiao et 
al. 2008] 
Hyperin  fluorescence, FRET [Bi et al. 2004] 
Icariin HSA  UV-Vis absorption, 
fluorescence 
[Zhang et al. 2008b] 
Isoquercetin BSA, HAS fluorescence  [Rawel et al. 2005, Rawel 
et al. 2006] 
Isoquercitrin BSA, HAS fluorescence  [Dufour and Dangles 
2005] 
Isorhamnetin BSA, HSA  fluorescence  [Dufour and Dangles 
2005] 
Kaempferol BSA fluorescence, CD, FTIR [Cao et al. 2008, Dufour 
and Dangles 2005, Tian et 
al. 2004b, Xiao et al. 
2008] 
HSA  UV-Vis absorption, 
fluorescence, CD, FTIR 
[Dufour and Dangles 
2005, Kanakis et al. 2006, 
Matei and Hillebrand 
2010, Tajmir-Riahi 2007] 
Morin BSA fluorescence  [Sentchouk and 
Bondaryuk 2007] 
HSA  UV-Vis absorption, 
fluorescence, FTIR 
[Qi et al. 2008, Xie et al. 
2006] 
Myricetin BSA fluorescence  [Cao et al. 2008, Tian et 




Naringenin HSA  fluorescence  [Dufour and Dangles 
2005] 
Naringin HSA  UV-Vis absorption, CD, 
fluorescence, FTIR, 
molecular modeling 
[Zhang et al. 2008c] 
Quercetin BSA UV-Vis absorption, CD, 
fluorescence, cyclic 
voltammetry 
[Bolli et al. 2010, Cao et 
al. 2008, Dufour and 
Dangles 2005, Liu et al. 
2010, Ni et al. 2009, 
Papadopoulou et al. 2005, 
Rawel et al. 2005, Rawel 
et al. 2006, Sentchouk 
and Bondaryuk 2007, Shi 
et al. 2011, Xiao et al. 
2008, Xiao et al. 2009, 
Zhang et al. 2011b] 





[Bi et al. 2004, Diniz et al. 
2008, Dufour and Dangles 
2005, Kaldas et al. 2005, 
Kanakis et al. 2006, Rawel 
et al. 2005, Rawel et al. 
2006,  Tajmir-Riahi 2007, 
Zsila et al. 2003] 




BSA UV-Vis absorption, 
fluorescence 
[Dufour and Dangles 
2005, Liu et al. 2010, 
Papadopoulou et al. 2005, 
Rawel et al. 2005, Rawel 
et al. 2006, Sentchouk 
and Bondaryuk 2007, Xiao 
et al. 2009] 
HSA  fluorescence, FRET, 
capillary 
electrophoresis 
[Bi et al. 2004, Diniz et al. 
2008, Dufour and Dangles 
2005, Rawel et al. 2005, 
Rawel et al. 2006] 
Tamarixetin BSA, HSA  fluorescence  [Dufour and Dangles 
2005] 
Troxerutin BSA UV-Vis absorption, 
fluorescence 
[Wang et al. 2009] 
Taxifolin BSA UV-Vis absorption, CD, 
fluorescence 






Flavanols Protein Applied techniques References 





native PAGE, SDS-PAGE 
[Arora et al. 1989, 
Bartolomé et al. 2000, 
Dufour and Dangles 2005, 
Hatano et al. 2003, 
Kusuda et al. 2006, 
Papadopoulou et al. 2005, 
Peng et al. 2012, Shi et al. 
2011, Soares et al. 2007, 
Zhang et al. 2011b] 




[Diniz et al. 2008, Dufour 
and Dangles 2005, Ishii et 
al. 2010a] 
 
(-)-Catechin gallate HSA  HPLC analysis with 
immobilized albumin 
column 
[Ishii et al. 2010a] 
(-)-Epicatechin BSA fluorescence  [Papadopoulou et al. 
2005, Soares et al. 2007] 






[Diniz et al. 2008, Frazier 




HSA  HPLC analysis with 
immobilized albumin 
column 
[Ishii et al. 2010a] 
(-)-Epigallocatechin 
 
BSA fluorescence  [Soares et al. 2007] 
HSA  HPLC analysis with 
immobilized albumin 
column 
[Ishii et al. 2010a] 
(-)-Epigallocatechin 
gallate 
BSA CD, size-exclusion 
chromatography, 
native PAGE, SDS-PAGE 
[Hatano et al. 2003, 
Kusuda et al. 2006,  
Nozaki et al. 2009] 
HSA  fluorescence, CD, FTIR, 
docking study, native 
PAGE, SDS-PAGE, 
western blotting, HPLC 
analysis with 
immobilized albumin 
column, quartz crystal 
microbalance 
[Bae et al. 2009, Ishii et al. 
2010a, Ishii et al. 2011, 
Maiti et al. 2006, Minoda 
et al. 2010, Nozaki et al. 
2009] 
(-)-Gallocatechin HSA  HPLC analysis with 
immobilized albumin 
column 





HSA  HPLC analysis with 
immobilized albumin 
column 
[Ishii et al. 2010a] 
Anthocyanidines Protein Applied techniques References 
Malvidin-3-
glucoside 
BSA fluorescence  [Soares et al. 2007] 
Delphinidin HSA  UV-Vis absorption, 
FTIR, capillary 
electrophoresis, CD 
[Kanakis et al. 2006, 
Tajmir-Riahi 2007] 
CD (circular dichroism), FRET (fluorescence resonance energy transfer), FTIR (Fourier transform infrared 
specroscopy), HPLC (high performance liquid chromatography), SDS PAGE (sodium dodecyl sulfate 
polyacrylamide gel electrophoresis), SPR (surface plasmon resonance) 
 
2.3.4 Protective activity of plant polyphenols against non-enzymatic glycation 
 Plant polyphenols with obvious antioxidant properties including hydroxycinnamic 
acids and flavonoids can act also as potential inhibitors of AGEs formation and thus 
reduce non-enzymatic glycation. It may take place by different mechanisms such as 
trapping of reactive oxygen species or reactive dicarbonyl compounds, chelating of 
transition metal ions [Gugliucci et al. 2009, Sang et al. 2007]. However, mechanisms of 
their anti-glycating actions have not been fully clarified [Wu and Yen 2005]. Several 
anti-glycating effects of hydroxycinnamic acids and flavonoids on different in vitro 
systems of glycation models have been already described and the examples are given 
in Table 6. It has been shown that the effectiveness of protection against protein non-
enzymatic glycation by flavonoids is attributed to their structure and antioxidant 
properties [Sang et al. 2007, Wu and Yen 2005]. It seems that also binding ability of 
naturally occurring substances towards biological macromolecule such as proteins may 
play a role in their anti-glycating activity [Kusuda et al. 2006]. Possible inhibitory 
effects of plant materials, which are significant source of polyphenolic compounds, on 
various in vitro glycation models have been investigated (Table 7).  
 
Table 6: Examples of in-vitro anti-glycating effect of HCAs and flavonoids. 
 
Plant polyphenol Protein + glycating agent References 
Baicalin AST + fructose *Boušová et al. 2005a] 
Baicalein AST + fructose *Boušová et al. 2005a] 
Caffeic acid 
 
BSA + methylglyoxal [Gugliucci et al. 2009, Lee et 
al. 2008] 
G.K. peptide + ribose [Lee et al. 2008] 
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(+)-Catechin BSA + fructose [Jang et al. 2009] 
BSA + glucose [Jang et al. 2009, Wu and Yen 
2005] 
BSA + methylglyoxal [Wu and Yen 2005] 
Collagen + glucose [Urios et al. 2007] 
G.K. peptide + ribose [Wu and Yen 2005] 
HbA1C + δ-gluconolactone  [Wu and Yen 2005] 
Chlorogenic acid 
 
BSA + glucose [Kim et al. 2011] 
BSA + methylglyoxal [Gugliucci et al. 2009] 
Collagen + glucose [Kim et al. 2011] 
o-Coumaric acid AST + fructose *Boušová et al. 2005a] 







BSA + fructose [Jang et al. 2009] 
BSA + glucose [Jang et al. 2009] 
BSA + glucose [Wu and Yen 2005] 
BSA + methylglyoxal [Wu and Yen 2005] 
G.K. peptide + ribose [Wu and Yen 2005] 
HbA1C + δ-gluconolactone  [Wu and Yen 2005] 
Eriodictyol BSA + glucose [Morimitsu et al. 1995] 
Feruloyl oligosaccharides BSA + glucose [Wang et al. 2009] 
Ferulic acid AST + fructose *Boušová et al. 2005a] 
Fisetin BSA + glucose [Lee et al. 2008] 
Fustin BSA + glucose [Lee et al. 2008] 
Genistein HSA + methylglyoxal [Lv et al. 2011] 
Isoferulic acid AST + fructose *Boušová et al. 2005a] 
Isovitexin BSA + glucose [Peng et al. 2008] 
BSA + methylglyoxal [Peng et al. 2008] 
Kaempferol BSA + glucose [Wu and Yen 2005] 
BSA + methylglyoxal [Wu and Yen 2005] 
Collagen + glucose [Urios et al. 2007] 
G.K. peptide + ribose [Wu and Yen 2005] 
HbA1C + δ-gluconolactone  [Wu and Yen 2005] 
Luteolin BSA + glucose [Wu and Yen 2005] 
BSA + methylglyoxal [Wu and Yen 2005] 
G.K. peptide + ribose [Wu and Yen 2005] 
HbA1C + δ-gluconolactone  [Wu and Yen 2005] 
Morin BSA + glucose [Lee et al. 2008] 
Myricetin Collagen + glucose [Urios et al. 2007] 
Naringenin BSA + glucose [Wu and Yen 2005] 
BSA + methylglyoxal [Wu and Yen 2005] 
G.K. peptide + ribose [Wu and Yen 2005] 
HbA1C + δ-gluconolactone  [Wu and Yen 2005] 
Proanthocyanidin B-4 BSA + fructose [Jang et al. 2009] 




Quercetin BSA + glucose [Lee et al. 2008, Morimitsu et 
al. 1995, Wu and Yen 2005] 
BSA + methylglyoxal [Wu and Yen 2005] 
Collagen + glucose [Cervantes-Laurean et al. 
2006] 
[Urios et al. 2007] 
G.K. peptide + ribose [Wu and Yen 2005] 
HbA1C + δ-gluconolactone  [Wu and Yen 2005] 
Rutin 
 
BSA + glucose [Peng et al. 2008, Wu and Yen 
2005] 
BSA + methylglyoxal [Peng et al. 2008, Wu and Yen 
2005] 
Collagen + glucose [Cervantes-Laurean et al. 
2006, Muthenna et al. 2011, 
Urios et al. 2007] 
G.K. peptide + ribose [Wu and Yen 2005] 
HbA1C + δ-gluconolactone  [Wu and Yen 2005] 
Vitexin BSA + glucose [Peng et al. 2008] 
BSA + methylglyoxal [Peng et al. 2008] 
AST (aspartate aminotransferase), G.K peptide (synthetic peptide containing lysine), HbA1C (hemoglobin) 
 
 
Table 7: Examples of in-vitro anti-glycating effect of plant extracts. 
 
Plant extracts Protein + glycating agent  References 
Aged garlic extract BSA + glucose [Amad et al. 2007] 
Lysozyme + glucose [Amad et al. 2007] 
Lysozyme + methylglyoxal [Amad et al. 2007] 
Apocynum venetum L. 
(Apocynaceae) 
BSA + fructose [Yokozawa and 
Nakagawa 2004] 
BSA + glucose [Yokozawa and 
Nakagawa 2004] 
Camellia sinensis  
(Theaceae) 
BSA + fructose [Nakagawa et al. 2002] 
BSA + glucose [Nakagawa et al. 2002] 
[Ho et al. 2010] 
BSA + methylglyoxal [Ho et al. 2010, 
Lunceford and Gugliucci 
2005] 
Chrysanthemum morifolium R. 
(Asteraceae) 
BSA + fructose [Tsuji-Naito et al. 2009] 
BSA + glucose [Tsuji-Naito et al. 2009] 
Chrysanthemum indicum L. 
(Asteraceae) 
BSA + fructose [Tsuji-Naito et al. 2009] 
BSA + glucose [Tsuji-Naito et al. 2009] 
Cymbopogon stratus 
(Cymbopogon) 
BSA + glucose [Ho et al. 2010] 
BSA + methylglyoxal [Ho et al. 2010] 
Cyperus rotundus 
(Cyperaceae) 






BSA + methylglyoxal [Lunceford and Gugliucci 
2005] 
Melissa officinalis  
(Lamiaceae) 
BSA + glucose [Ho et al. 2010] 
BSA + methylglyoxal [Ho et al. 2010] 
Mentha longifolia 
 (Lamiaceae) 
BSA + glucose [Ho et al. 2010] 
BSA + methylglyoxal [Ho et al. 2010] 
Nelumbo nucifera 
(Nelumbonaceae) 
BSA + fructose [Jung et al. 2008] 
BSA + glucose [Jung et al. 2008] 
Passiflora alata 
(Passifloraceae) 
BSA + fructose [Rudnicki et al. 2007] 
BSA + glucose [Rudnicki et al. 2007] 
Passiflora edulis 
(Passifloraceae) 
BSA + fructose [Rudnicki et al. 2007] 
BSA + glucose [Rudnicki et al. 2007] 
Psidium guajava L. 
(Myrtaceae) 
BSA + glucose [Wu et al. 2009] 
Rosmarinus officinalis 
(Lamiaceae) 
BSA + glucose [Ho et al. 2010] 
BSA + methylglyoxal [Ho et al. 2010] 
Salvia officinalis  
(Lamiaceae) 
BSA + glucose [Ho et al. 2010] 
BSA + methylglyoxal [Ho et al. 2010] 
Sorghum bicolor 
(Poaceae) 
BSA + fructose [Farrar et al. 2008] 
BSA + methylglyoxal [Farrar et al. 2008] 
Teucrium polium 
(Lamiaceae) 
BSA + glucose [Ardestani and 
Yazdanparast 2007b] 




BSA + glucose [Ho et al. 2010] 
BSA + methylglyoxal [Ho et al. 2010] 




2.4 MODEL PROTEINS TO STUDY GLYCATION AND LIGAND-PROTEIN INTERACTIONS 
Several model proteins have been selected for purposes of the experiments 
dealing with protein-polyphenol interactions and non-enzymatic glycation processes. 
These include serum albumins and enzymes such as a multifunctional thiol-disulfide 
oxidoreductase ERp57 and a glutathione S-transferase. Their structures and properties 
are briefly described below. 
 
2.4.1 Serum albumin 
Serum albumin (65 kDa) is the most abundant protein in blood plasma with a 
typical concentration of 50 g/l and one of the most extensively studied proteins [Peters 
1996]. The crystallographic analysis of serum albumin revealed that the protein 
contains three structurally similar domains (I–III), which assemble to form heart-
shaped molecule. Each of these domains is further divided into two subdomains (A and 
B) [Carter and Ho 1994]. It was found out that aromatic and heterocyclic ligands bind 
within two hydrophobic pockets in subdomains IIA and IIIA corresponding to Sudlow´s 
site I and II, respectively [Otagiri 2005]. Human (HSA) and bovine (BSA) serum albumins 
are the most used model proteins. They are cross-linked with 17 disulfide bonds and 
comprise of 585 and 583 amino acid residues in their polypeptide chains for HSA and 
BSA, respectively. HSA differs from BSA by 24% of primary structure [Peters 1996]. 
Serum albumin possesses a wide range of physiological functions involving the 
binding, transport, and deposition of many endogenous and exogenous ligands such as 
nutrients, hormones, fatty acids, and many diverse drugs present in blood circulation. 
It is well known that the deposition, transportation, metabolism, and efficacy of drugs 
are strongly affected by their binding to serum albumin [Peters 1996, Varshney et al. 
2010]. On the other hand, ligands can cause various changes in protein conformation 
influencing its physiological function and such impaired proteins may be consequently 
pathologically accumulated in body tissues. Thereby, the studies of serum albumin-
drug interactions play an important role in pharmacology and pharmacodynamics 
[Bertucci and Domenici 2002]. 
From spectroscopic point of view, the presence of the aromatic amino acid 
residues in proteins, mainly tryptophan residue(s), are important for effective 
revealment of protein conformational changes due to the changes in the 
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microenvironment of the tryptophan residue(s) [Lakowicz 2006]. Bovine serum 
albumin (BSA) contains two tryptophan residues. One is located near the surface in 
domain IB (Trp-134) and the second one is buried in a hydrophobic (non-polar) pocket 
in the internal part of domain IIA (Trp-212). Although Trp-134 is more accessible to 
drug binding than Trp-212, the second one is known to bind a variety of ligands in its 
hydrophobic pocket. Readiness of the drug penetration to Trp-212 also depends on its 
structure and character. Human serum albumin (HSA) has only one tryptophan residue 
(Trp-214) within a hydrophobic binding pocket of subdomain IIA (Figure 7), which 
significantly contributes to the intrinsic fluorescence of this protein [Carter and Ho 
1994].  
Serum albumin is also a target for various glycating agents during non-enzymatic 
glycation process, i.e. formation of a Schiff base between ε-amino groups of lysine or 
arginine residues and reducing sugars or their metabolites. HSA and BSA contains 59 




Figure 7: Structure of human serum albumin [Bolli et al. 2010]. 
The sole tryptophan residue (Trp-214, W-214) residue in hydrophobic pocket is 
highlighted in red. Fatty acid binding sites are indicated by arrows and labeled. Oleate 
molecules bound to fatty acid sites (represented as space filled) are shown in blue. The 
Sudlow´s site I and II are showed. 
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2.4.2 Protein ERp57 
ERp57 (58 kDa) is a multifunctional thiol-disulfide oxidoreductase (EC 5.3.4.1) that 
is highly similar to the protein disulfide isomerase (PDI) family members in terms of 
amino acid sequence and structural/functional domain organization [Wang et al. 
2010]. However, it possesses some distinctive structural features that dictate its 
unique functions within the cells [Coe and Michalak 2010, Maattanen et al. 2006, 
Silvennoinen et al. 2004]. ERp57 is localized mainly in the endoplasmic reticulum (ER) 
of eukaryotic cells where it plays numerous physiological functions. Two major and the 
most studied roles of ERp57 are: (i) a key molecular player in the quality control of 
newly synthesized glycoproteins, together with the lectine-like ER chaperones calnexin 
and calreticulin [Jessop et al. 2007, Oliver et al. 1997], and (ii) involvement in the 
assembly of the MHC (Major Histocompatibility Complex) class I molecules [Dong et al. 
2009, Wearsch and Cresswell 2008]. However, ERp57 has been found also outside of 
the ER in the nucleus, cytoplasm and cell surface, and involved in gene regulation 
[Coppari et al. 2002, Khanal and Nemere 2007, Turano et al. 2002]. Its numerous 
functions are linked to many disease states predicting cancer, prion disorders, 
Alzheimer's disease, and hepatitis, and it makes ERp57 as a probable target for 
developing novel strategies for treatment and early diagnosis of these diseases 
[Erickson et al. 2005, Hetz et al. 2005, Martin et al. 1993, Seliger et al. 2001]. 
The overall domain construction of ERp57 is abb’a’c (Figure 8), where domains a 
and a´are two thioredoxin-like catalytic domains, while b and b´ are two thioredoxin-
like non-catalytic domains, and c is a basic carboxyl terminal domain with C-terminal 
ER retention sequence (QEDL). Each of the a and a´ domains contains the catalytically 
redox-active WCGHCK1 motif and is capable of catalyzing simple oxido-reductions and 
thiol-disulfide exchange reactions [Frickel et al. 2004, Kozlov et al. 2006]. The b and b´ 
domains provide the principal substrate binding sites for the lectine-like chaperones 
calnexin and calreticulin [Urade et al. 2004], the a domain is critical for forming 
disulfide bonds during interaction of ERp57 with chaperone tapasin within the MHC 
class I peptide-loading complex [Peaper et al. 2005]. The DNA binding activity of ERp57 
is associated with the a´ domain [Grillo et al. 2002] and related to its redox-dependent 
conformational changes [Grillo et al. 2007]. The ERp57 interacts also with Ref-1 
                                                 
1
 Amino acid sequence motif of redox-active sites of ERp57 (Trp–Cys–Gly–His–Cys–Lys). 
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protein, which is involved in DNA repair as well as in the reduction and activation of 
transcription factors [Grillo et al. 2006], Stat32 [Guo et al. 2002], and is involved in 
Stat3-DNA complexes [Eufemi et al. 2004]. High binding affinities of several antibiotics 
to ERp57 and their inhibitory effects on the reductase activity of the protein have been 
described [Gaucci et al. 2008]. From the spectroscopic point of view, the presence of 
three tryptophan residues in ERp57 molecule is important. They unequally contribute 
to the protein intrinsic (tryptophan) fluorescence. One residue is buried in a 
hydrophobic pocket of the b´domain, whereas the other two residues are located on 
the protein surface close to the active like-thioredoxin sites in domains a and a´, 





Figure 8: Structure and domain organization of ERp57 [Coe and Michalak 2010]. 
ERp57 has a N-terminal amino acid signal sequence (white), catalytic a and a’ domains 
(light grey) with catalytic residues (CGHC, yellow), substrate binding b and b’ domains 
(dark grey) connected with a linker region (orange), a basic C-terminal tail (violet) and 
a C-terminal ER-retention signal (QEDL). Amino acids involved in calnexin binding are 
indicated in blue and disulfide bond in the a domain is marked. 
                                                 
2
Signal Transducer and Activator of Transcription 3 - a member of the STAT family of transcription 
factors, participates in the regulation of expression of genes involved in the immune response, in 
inflammation, in cell survival and in cell proliferation [Lee et al. 2011]. 
54 
 
2.4.3 Gluthathione S-transferase 
Glutathione S-transferases (GST, EC 2.5.1.18) represent a group of xenobiotic-
metabolizing enzymes that play a crucial role in the phase II of detoxification. These 
enzymes catalyze conjugation of toxic compounds with endogenous tripeptide 
glutathione (GSH) in order to deactive them and increase their hydrophobilicity 
[Uetrecht and Trager 2007]. GSTs are extremely ubiquitous, e.g. constituting about 4% 
of soluble protein in the liver [van Bladeren 2000]. They can be divided into three 
subfamilies according to the cellular localization: cytosolic, microsomal, and 
mitochondrial. Among them, cytosolic GSTs are numerous and well described. Seven 
classes of mammalian cytoslic GSTs, called alpha, kappa, mu, omega, pi, theta, and 
zeta, have been identified and categorized based on a sequence identity (at least 40% 
sequence identity within a class) [Dourado at al. 2008, Nebert and Vasiliou 2004, 
Sheehan et al. 2001]. The most widely distributed GST isoforms come from alpha, mu, 
and pi classes [Dourado at al. 2008]. These enzymes exist as dimeric proteins, with an 
approximate molecular weight of 25 kDa for each subunit (Figure 9). Each of the 
subunits possesses a GSH binding site (G-site) as well as an adjacent relatively 
hydrophobic site (H-site) for the binding of the electrophilic substrate [van Bladeren 
2000, Mannervik and Danielson 1988]. Other details are described in chapter 5.5. 
 
 
Figure 9: Structure of non-fusion GST from Schistosoma japonicum in complex with 
glutathione. GST contains α-helix parts (ping), ß-pleated sheet parts (yellow), and their 




3 RESEARCH OBJECTIVES 
The main aim of this work has been focused on study of effects of naturally 
occurring dietary polyphenols (i.e. hydroxycinnamic acids and catechins) on protein 
conformation, protein binding ability, enzyme activity, and protein glycation processes 
in the in vitro models to evaluate their structure-activity relationships. Moreover, 
study of methylglyoxal-mediated glycation of model protein has been also performed. 
Spectroscopic, especially fluorescence methods, and electrophoretic (native PAGE, SDS 
PAGE, western blotting) methods were applied for these purposes. 
 
Interaction of selected dietary plant polyphenols with model proteins 
(i) In vitro study of interaction between hydroxycinnamic acids (HCAs) and bovine 
serum albumin (BSA) by fluorescence quenching method 
(ii) In vitro study of interaction between catechins and human serum albumin (HSA) 
by spectroscopic (fluorescence quenching method and UV-Vis spectroscopy) and 
electrophoretic methods (native PAGE and SDS PAGE) 
(iii) In vitro study of interaction between green tea catechins (GTCs) and ERp57 
protein by fluorescence quenching method 
 
Effect of selected dietary plant polyphenols on enzyme activity of model protein 
(i) In vitro study of effect of green tea catechins (GTCs) on disulfide reductase activity 
of the ERp57 protein by sensitive fluorescent assay 
 
Methylglyoxal-mediated non-enzymatic glycation of model proteins 
(i) In vitro study of methylglyoxal-mediated non-enzymatic glycation process of 
glutathione S-transferase by spectroscopic (fluorescence and UV-Vis spectroscopy) 
and electrophoretic (native PAGE and western blotting) methods 
(ii) In vitro study of effect of green tea catechins (GTCs) on methylglyoxal-mediated 








Albumin from bovine serum (min. 98% electrophoresis):  
Sigma-Aldrich Co., St. Louis, USA 
Albumin from human serum (lyophilized powder, ≥99%):  
Sigma-Aldrich Co., St. Louis, USA 
Endoplasmic reticulum protein 57 (ERp57):  
protein preparation by prof. Altieri [Grillo et al. 2002] 
Glutathione S-transferase (a recombinant enzyme from Schistosoma japonicum): 
GenScript, New Jersey, USA 
 
Hydroxycinnamic acids: Sigma-Aldrich Co., St. Louis, USA 
Caffeic acid (min. 99% HPLC, crystalline) 
Chlorogenic acid (min. 95% titration) 
m-Coumaric acid (trans-3-hydroxycinnamic acid, 99%) 
o-Coumaric acid (≥97% HPLC) 
p-Coumaric acid (min. 98% HPLC) 
Ferulic acid (trans-4-hydroxy-3-methoxy-cinnamic acid, 99%) 
Rosmarinic acid (min. 96%) 
Sinapic acid (p.a. matrix substance for MALDI-MS, 99%) 
 
Catechins (flavan-3-ols) : Sigma-Aldrich Co., St. Louis, USA 
(-)-Catechin (from green tea, ≥98%) 
(-)-Catechin gallate (from green tea, ≥98%) 
(-)-Epicatechin (from green tea, ≥98%) 
(-)-Epicatechin gallate (from green tea, ≥98%) 
(-)-Epigallocatechin (from green tea, ≥95%) 
(-)-Epigallocatechin gallate (from green tea, ≥95%) 
(-)-Gallocatechin (from green tea, ≥98%) 





Acrylamide (for electrophoresis, ≥99%): Sigma-Aldrich Co., St. Louis, USA 
β-alanine: Sigma-Aldrich Co., St. Louis, USA 
Aminoguanidine hydrochloride (≥98%): Sigma-Aldrich Co., St. Louis, USA 
Ammonium persulfate (for electrophoresis, ≥98%): Sigma-Aldrich Co., St. Louis, USA 
Bromophenol blue: Riedel-de Haën, Steinheim, Germany 
Chemiluminescent/fluorescent substrate for alkaline phosphatase DuoLux: Vector 
Laboratories, Burlingame, USA 
1-Chloro-2,4-dinitrobenzene: Sigma-Aldrich Co., St. Louis, USA 
Coomassie Blue G250 (EZBlue gel staining reagent): Sigma-Aldrich Co., St. Louis, USA 
DL- Dithiothreitol (≥99%): Sigma-Aldrich Co., St. Louis, USA 
Ethanol (p.a.): Sigma-Aldrich Co., St. Louis, USA 
Ethylenediaminetetraacetic acid (anhydrous, ≥99%): Sigma-Aldrich Co., St. Louis, USA 
N-Ethylmaleimide (purum p.a., ≥99%): Sigma-Aldrich Co., St. Louis, USA 
Fixing and developing bath: Foma Bohemia, Hradec Králové, Czech Republic 
L-Glutathione oxidized (≥98%): Sigma-Aldrich Co., St. Louis, USA  
L-Glutathione reduced (≥98%): Sigma-Aldrich Co., St. Louis, USA 
Glycerol (for molecular biology, ≥98%): Sigma-Aldrich Co., St. Louis, USA 
Glycine for electrophoresis (≥99%): Sigma-Aldrich Co., St. Louis, USA 
Goat polyclonal anti-rabbit IgG antibody conjugated with alkaline phosphatase 
(secondary antibody): Acris GmbH, Hiddenhausen, Germany 
2-Mercaptoethanol (electrophoresis reagent, ≥98%): Sigma-Aldrich Co., St. Louis, USA 
Methanol (p.a.): Penta, Prague, Czech Republic 
N,N´-Methylenebisacrylamide (for electrophoresis, ≥98%):  
Sigma-Aldrich Co., St. Louis, USA 
Methylglyoxal (aqueous solution, 40%): Sigma-Aldrich Co., St. Louis, USA 
Mouse monoclonal antibody [3C] to MGO-derived AGEs (primary antibody):  
Abcam plc, Cambridge, UK 
Non-fat dry milk: Bio-Rad Laboratories, Hercules, USA 
Precision Plus molecular weight standards: Bio-Rad Laboratories, Hercules, USA 
Rabbit polyclonal antibody to AGE (primary antibody):  
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Acris GmbH, Hiddenhausen, Germany 
Rabbit polyclonal anti-mouse IgG antibody conjugated with alkaline phosphatase  
(secondary antibody): Abcam plc, Cambridge, UK 
Sodium azide: Lachema, Brno, Czech Republic 
Sodium dodecyl sulfate: Sigma-Aldrich Co., St. Louis, USA 
Sodium isothiocyanate (ACS reagent, ≥98%): Sigma-Aldrich Co., St. Louis, USA 
N,N,N´,N´-Tetramethylethylendiamine (for molecular biology): Sigma-Aldrich Co., St.  
Louis, USA 
2,4,6-Trinitrobenzenesulfonic acid: Sigma-Aldrich Co., St. Louis, USA 
Tris(hydroxymethyl)aminomethane (Tris, ACS reagent, ≥99.8%): Sigma-Aldrich Co., St. 
Louis, USA 
Trolox ((±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid, ≥97%): Sigma-
Aldrich Co., St. Louis, USA 
X-ray films CL-XPosure: Thermo Fisher Scientific, Rockford, USA 
 
Buffers 
Buffers were prepared using common chemicals of analytical grade and redistilled 
water. 
Phosphate buffered saline system (PBS, 0.01 M, pH 7.4) 
Sodium phosphate buffer (0.1 M, pH 7.4) 
Sodium phosphate buffer with sodium azide (0.1 M, pH 7.4, 0.05% sodium azide) 
Potassium phosphate buffer (0.1 M, pH 7.0, 2 mM EDTA) 
Potassium phosphate buffer (0.1 M, pH 8.8, 2 mM EDTA) 
Tris buffer (0.1 M, pH 8.0) 
Tris buffer (0.1 M, pH 9.5, 5 mM MgCl2.6H2O)  
Tris buffer saline (TBS) 
Tris buffered saline-Tween-20 buffer (TBST) 
Tris-HCl buffer (1.5 M, pH 8.8) 
Tris-HCl buffer (0.5 M, pH 6.8) 
Tris-glycine buffer (0.6 M, pH 8.3) (concentrated running buffer for native PAGE) 




4.2 SOLUTION PREPARATIONS 
Redistilled water was used for preparation of all aqueous solutions. 
 
4.2.1 Stock protein solutions 
Bovine serum albumin was dissolved in sodium phosphate buffer (0.1 M, pH 7.4, 
0.05% sodium azide) in order to yield solution with concentration of 2 x 10-6 M. Human 
serum albumin was dissolved in sodium phosphate buffer (pH 7.4, 0.1 M, 0.05% 
sodium azide) in order to yield solutions with concentration of 4 x 10-6 M and 15 x 10-6 
M for spectroscopic measurements and electrophoresis, respectively. ERp57 and GST 
were dissolved in PBS (0.01 M, pH 7.4) in order to yield stock solutions with 
concentrations of 5 x 10-7 M and 19 x 10-9 M (1 mg/ml), respectively. 
 
4.2.2 Stock polyphenolic solutions 
Individual polyphenols were dissolved in anhydrous methanol in order to yield 10 
mM stock solutions that were stored at -20°C until use. 
 
4.2.3 Sample preparation and incubation 
 
4.2.3.1 Protein sample preparation 
 Stock protein solutions of BSA (2 x 10-6 M), HSA (4 x 10-6 M), and ERp57 (15 x 10-6 
M) have been used for fluorescence quenching measurements without further 
dilution. 
 
4.2.3.2 HSA sample preparation and incubation 
Samples with and without (controls) tested catechins were prepared as follows. 
Protein concentration in all samples was 15 x 10-6 M and concentration of catechins 
was 6 x 10-4 M. Samples were incubated for 30 minutes at 37°C and further analyzed 
using polyacrylamide gel electrophoresis under non-denaturating (native PAGE) or 






4.2.3.3 GST sample preparation and incubation 
Stock solution of GST (1 mg/ml) was diluted by sodium phosphate buffer (0.1 M, 
pH 7.4) in order to yield 0.025 mg/ml solution for enzyme activity assay. 
GST (0.5 mg/ml) was incubated in the absence or presence of methylglyoxal (0.5, 
1, and 2 mM) at 37 °C for up to 14 days in 100 mM phosphate-buffered saline (pH 7.4, 
0.05% sodium azide). Low-molecular compounds were removed using Microcon 
centrifugal filtration device with 10 mM phosphate-buffered saline (pH 7.4). The 
protein content was determined using Bradford assay and adjusted to the 
concentration 0.5 mg/ml. Aliquots were stored frozen at -20 °C until analysis. All the 
samples were assessed in triplicates and experiments were repeated twice if not 
stated otherwise. 
 
4.2.4 Stock solutions for polyacrylamide gel electrophoresis 
 
4.2.4.1 Stock solution containing acrylamide and bis-acrylamide 
 Thirty g of acrylamide (AA) and 0.8 g of N,N´-methylenebisacrylamide (bis-AA) 
were dissolved in 100 ml of redistilled water. 
 
4.2.4.2 Stock solution of bromophenol blue 
Fifty mg of bromophenol blue (BPB) were dissolved in 10 ml of redistilled water in 
order to yield solution with concentration of 0.5%. 
 
4.2.4.3 Stock solution of ammonium persulfate 
Twenty-five mg of ammonium persulfate (APS) were dissolved in 250 μl of 
redistilled water in order to yield solution with concentration of 10%. 
 
4.2.4.4 Stock solution of sodium dodecyl sulfate 
Ten g of sodium dodecyl sulfate (SDS) were dissolved in 100 ml of redistilled water 






4.2.4.5 Running buffers 
Concentrated running buffers were diluted by redistilled water in ratio 1:4 in order 
to yield running buffers for native and SDS PAGE. 
 
4.2.4.6 Sample buffers and samples 
Sample buffer for native PAGE was prepared by mixing 1 ml of Tris-HCl buffer (0.5 
M, pH 6.8), 4.3 ml of redistilled water, 2 ml of glycerol, and 0.6 ml of BPB (0.5%). 
Protein samples were diluted by sample buffer in ratio 1:1.  
Sample buffer for SDS PAGE was prepared by mixing 1 ml of Tris-HCl buffer (0.5 M, 
pH 6.8), 1.3 ml of redistilled water, 2 ml of glycerol, 3 ml of SDS (10%), and 0.6 ml of 
BPB (0.5%). Consecutively, 50 l of 2-mercaptoethanol was added into 1 ml of sample 
buffer with SDS. Protein sample (12 μl) was diluted by 3 μl of SDS (10%) and 15 μl of 
sample buffer containing SDS and 2-mercaptoethanol. 
 
4.2.5 Preparation of polyacrylamide gels 
Table 8: Preparation of non-denaturating polyacrylamide gel for native PAGE. 
Preparation for 1 gel Separating gel (10%) Stacking gel (4%) 
Redistilled water 4000 μl 3176 μl 
Tris-HCl buffer (1.5 M, pH 8.8) 2500 μl 1250 μl 
Solution (AA + bis-AA) 3400 μl 500 μl 
APS (10%) 116 μl 100 μl 
TEMED 8 μl 10 μl 
Acrylamide (AA), ammonium persulfate (APS), N,N´-methylenebisacrylamide (bis-AA), N,N,N´,N´-
tetramethylethylendiamine (TEMED). 
 
Table 9: Preparation of denaturating polyacrylamide gel for SDS PAGE. 
Preparation for 1 gel Separating gel Stacking gel 
 10% 12.5% 4% 
Redistilled water 2450 μl 1600 μl 1563 μl 
Tris-HCl buffer (1.5 M, pH 8.8) 1250 μl 1250 μl 625 μl 
Solution (AA + bis-AA) 50 μl 50 μl 25 μl 
SDS (10%) 1250 μl 2100 μl 250 μl 
APS (10%) 116 μl 116 μl 100 μl 
TEMED 8 μl 8 μl 10 μl 
Acrylamide (AA), ammonium persulfate (APS), N,N´-methylenebisacrylamide (bis-AA), sodium dodecyl 





4.3 APPLIED METHODS AND INSTRUMENT EQUIPMENTS 
 
4.3.1 UV-Vis absorption spectroscopy 
All absorption spectra were recorded using a spectrophotometer Helios β 
(Spectronic Unicam, United Kingdom) in a 10 mm quartz cuvette. 
 
4.3.1.1 Stability of polyphenolic solutions 
UV-Vis absorption spectroscopy was employed to check stabilities of polyphenol 
solutions during long-term incubation. Fifty micromolar solutions of the tested 
catechins or HCAs in sodium phosphate buffer (pH 7.4, 0.1 M, 0.05% sodium azide) 
were incubated at 37°C for up to 15 or 28 days, respectively. The absorption spectra 
were recorded at the time 0 and in the selected time intervals from 190 to 550 nm at 
37°C. Time-dependent changes in the characteristic spectra of individual polyphenols 
were observed to obtain information about their stabilities. 
 
4.3.1.2 Complex formation between catechins and HSA 
Possibility of complex formation between catechins and human serum albumin 
was probed by UV-Vis absorption spectroscopy as an additional method. Solutions 
containing HSA (4 x 10-6 M) and individual catechins (4 x 10-5 M) were incubated for 5 
minutes at 37°C (*HSA+/[catechin] = 1/10) and consecutively absorption spectra were 
recorded from 190 to 550 nm at 37°C. The spectrum of sodium phosphate buffer (0.1 
M, pH 7.4, 0.05% sodium azide) with or without appropriate catechin was substracted 
and the obtained differential spectrum was compared with protein spectrum in time 0. 
 
4.3.1.3 Glutathione transferase activity assay 
GST (0.025 mg/ml) was incubated in the absence or presence of methylglyoxal 
(0.5, 1, and 2 mM) for 180 min at 37°C in sodium phosphate buffer (0.1 M, pH 7.4). 
Sample aliquots were taken away at 0, 60, 120, and 180 min, diluted, and their activity 
was assessed by colorimetric method based on the GST-catalyzed reaction between 
GSH and GST substrate 1-chloro-2,4-dinitrobenzene at pH 6.5. Product of the reaction, 
S-(2,4-dinitrophenyl)glutathione, was detected spectrophotometrically at 340 nm 
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[Habig et al. 1974]. Catalytic activity of GST was expressed as percentage of control 
sample activity at all time intervals, which was considered 100% ± SD (%). 
 
4.3.1.4 Determination of amino groups of GST 
Amine content, which is a measure of protein glycation extent, was estimated 
spectrophotometrically with trinitrobenzenesulfonic acid using β-alanine as the 
standard [Steinbrecher 1987]. Sample containing 50 μg of GST was incubated with 
0.1% trinitrobenzenesulfonic acid in alkaline conditions for 2 h at 37°C. The reaction 
was stopped by acidification (1 M HCl) and addition of 10% SDS. The absorbance of 
trinitrophenyl-amino acid complex was measured at 340 nm. The standard curve was 
linear in the range 5-100 nmol of NH2. 
 
4.3.2 Fluorescence spectroscopy 
 
4.3.2.1 Fluorescence spectra of complex between catechins and HSA 
Fluorescence emission spectra of individual catechins (4 x 10-5 M) with or without 
HSA (4 x 10-6 M) were recorded at the excitation wavelength of 330 nm corresponding 
to the absorption maximum of ground state complex. 
 
4.3.2.2 Fluorimetric titration: polyphenol-serum albumin systems 
Fluorescence spectra for study of polyphenol-serum albumin interactions were 
recorded using a luminescence spectrometer LS-50B (Perkin Elmer, United Kingdom) in 
a 10 mm quartz Suprasil fluorescence cuvette (Hellma, Germany) at 37°C. Fluorescence 
emission spectra were recorded from 300 to 530 nm with excitation wavelength of 295 
nm (intrinsic/tryptophan protein fluorescence) while stirring. The excitation and 
emission slits were both set to 5 nm and scanning speed was 200 nm.min-1. 
Quantitative analyses of the potential interaction between the studied polyphenols 
and serum albumin were performed by fluorimetric titration. Briefly, solutions of BSA 
(2 x 10-6 M) or HSA (4 x 10-6 M) were titrated in cuvette by successive additions of HCA 
or catechin solutions (1 x 10-2 M) to a final concentration of 2 x 10-5 M, respectively. 
Fluorescence of individual polyphenols (0-2 x 10-5 M) was recorded as blanks under the 
same experimental conditions and subtracted from the corresponding sample to 
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correct the fluorescence background. Fluorescence intensities were read at emission 
wavelength of 350 nm and 348 nm for HCA-BSA and catechin-HSA systems, 
respectively.  
 
4.3.2.3 Fluorimetric titration: green tea catechin-ERp57 systems 
Fluorescence emission spectra were recorded on a FluoroMax spectrofluorimeter 
(Horiba Jobin Yvon, UK) using a 1 cm path length quartz cuvette from 300 to 500 nm 
with excitation at 290 nm under continuous stirring. The excitation and emission slits 
were both set to 5 nm and scan speed was 120 nm·min-1. Quantitative analyses of the 
potential interaction between green tea catechins and protein was performed by the 
fluorimetric titration in PBS (0.01 M, pH 7.4) containing dithiothreitol (DTT, 1 x 10-4 M) 
and ethylenediaminetetraacetic acid (EDTA, 2 x 10-4 M) at 25°C. Briefly, ERp57 (5 x 10-7 
M) was titrated in cuvette by successive additions of individual catechin (1 x 10-3 M) to 
a final concentration of 2 x 10-5 M. Fluorescence intensities were read at protein 
emission maximum of 338 nm. Appropriate blanks (samples without proteins) under 
the same experimental conditions were subtracted from the corresponding samples to 
correct the fluorescence background. Quenching effect of the quenchers on ERp57 was 
calculated using the following equation: 
 
Q = (1 – F/F0) x 100% (8) 
 
where Q is the quenching fraction (%), F and F0 are fluorescence intensities in the 
presence and absence of the quencher. 
 
4.3.2.4 Fluorimetric titration: analysis of data 
Fluorescence quenching spectra were used for appraisal of protein conformational 
changes induced by polyphenols. The obtained fluorescence data were used for Stern-
Volmer analysis, determination of binding parameters, and estimation of the distances 
between protein and polyphenol by FRET. Principles and procedures of these analyses 
are briefly described in chapters “2.3.3.1.2 Fluorescence spectroscopy” and “2.3.3.1.3 




4.3.2.5 Disulfide reductase activity of ERp57 
Disulfide reductase activity of ERp57 was monitored by sensitive fluorescent assay 
using dieosin glutathione disulfide (Di-E-GSSG) as fluorogenic probe. Di-E-GSSG was 
synthesized by the reaction of eosin isothiocyanate with glutathione disulfide (GSSG) 
according to the method of Raturi and Mutus [Raturi and Mutus 2007] with some 
modifications. Briefly, GSSG (1 x 10-4 M) was incubated with 10-fold molar excess of 
eosin isothiocyanate (1 x 10-3 M) in potassium phosphate buffer (0.1 M, pH 8.8, 2 mM 
EDTA) at room temperature. Two hundred microliters of the suspension was passed 
down the G-25 column (100 x 10 mm, 10 ml) using the potassium phosphate buffer 
(0.1 M, pH 7.0, 2 mM EDTA) and 1.5 ml of appropriate aliquots were collected. The 
final concentration of Di-E-GSSG was determined spectrophotometrically (Ɛ525 = 88,000 
M-1 cm-1). ERp57 stock solution (1 x 10-6 M) was used to prepare four types of 
incubation samples: (a) with buffer only as control (potassium phosphate buffer, 0.1 
M, pH 7.0, 2 mM EDTA); (b) with N-ethylmaleimide (NEM, 4 x 10-4 M) as positive 
control; (c) with vancomycin (VM, 1 x 10-4 M) as positive control; (d) with individual 
green tea catechins (GTCs, 1 x 10-4 M). The last incubation sample containing BSA (1 
mg/ml) was used as negative control. Samples were incubated for 15 minutes at room 
temperature. Kinetic fluorescence measurements for determination of ERp57 disulfide 
reductase activity was monitored at 545 nm with excitation at 520 nm for 60 seconds 
at 25°C with continuous stirring. Scan speed was 60 nm.min-1 and the excitation and 
emission slits were both set to 5 nm. Twenty microlitres of incubation sample aliquot 
was added into potassium phosphate buffer (0.1 M, pH 7.0, 2 mM EDTA) containing Di-
E-GSSG (1.5 x 10-7 M) and DTT (5 x 10-6 M). The relative disulfide reductase activity (%) 
was calculated as: (kx – k0)/(k1 – k0) x 100%, where k1, kx, and k0 are the slopes of ERp57 
protein alone, ERp57 in the presence of GTC, NEM, or VM, and BSA protein alone, 
respectively. 
 
4.3.2.6 Fluorescent AGEs formation in HSA induced by methylglyoxal 
Human serum albumin (1 mg/ml) was preincubated with catechins at different 
concentrations (0-5 x 105 M) in PBS (0.01 M, pH 7.4, 0.05% sodium azide) at room 
temperature for 30 minutes. Consequently, methylglyoxal (1 mM MGO) was added 
into the mixtures which were then incubated at 37°C for 7 days. The aliquots were 
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taken away at time 0, 3 and 7 days, and stored frozen at -20°C. Low-molecular 
compounds were removed using Microcon centrifugal filtration device with PBS (0.01 
M, pH 7.4). The protein content was determined using Lowry assay and adjusted to the 
concentration 0.5 mg/ml. Formation of total fluorescent AGEs and argpyrimidine were 
measured at the excitation/emission wavelength of 340/410 nm and 320/380 nm 
against corresponding blanks in 96-well-plate by a microplate reader (Tecan Infinity 
M200) using 0.2 mg of protein per well. The % inhibition of AGEs formation = [1-
(fluorescence of the test group/fluorescence of the glycated control)] x 100%. Trolox 
(2.5 mM) and aminoguanidine (1 mM) were used as positive controls. Aliquots of time 
0 were used as unincubated blanks. All the samples were assessed in triplicates and 
experiments were repeated twice if not stated otherwise. 
 
4.3.2.7 Fluorescent AGEs formation and conformational changes in GST induced by 
methylglyoxal 
Formation of total fluorescent AGEs and changes in tryptophan (intrinsic) 
fluorescence were determined using a microplate reader (Tecan Infinite M200). 
Fluorescence was measured at excitation and emission wavelengths of 370/440 nm 
(total fluorescent AGEs) and 295/386 nm (tryptofan fluorescence), respectively, in 96-
well plate using 100 μg of GST per well. Emission wavelength for tryptophan 
fluorescence determination was found experimentally. Fluorescence data were 
expressed in relative fluorescence units ± SD. 
 
4.3.3 Native polyacrylamide gel electrophoresis 
 
4.3.3.1 Effect of catechins on molecular charge of HSA 
Native PAGE was performed in discontinuous system with 4% stacking gel and 10% 
separating non-denaturating gel. All lanes were loaded with 8 μg of protein. 
Electrophoresis was performed at 30 mA using Mini ProteanIII apparatus (BioRad). The 
gel was stained with colloidal Coomassie Blue G250, scanned by GelDoc XR system 
(BioRad), and the relative mobilities (Rf) were calculated using Quantity One software 
(BioRad). Results were further expressed as a rise in percentage of sample mobility 




4.3.3.2 Effect of methylglyoxal on molecular charge of GST 
Native PAGE was used to investigate the change in the molecular charge of GST 
due to glycation process. Electrophoresis was performed in Ornstein–Davies 
discontinuous system with 4% stacking gel and 10% separating non-denaturating gel 
[Ornstein 1964, Davies 1964]. All lanes were loaded with 10 μg of protein. 
Electrophoresis was performed at 30 mA for about 3 h using Mini ProteanIII apparatus. 
The gel was then stained by colloidal Coomassie Blue G250, scanned, and relative 
migration distances were calculated from Rf using Quantity One software (BioRad). 
Electrophoretic mobilities were expressed as a rise in percentage mobility compared 
with the native enzyme (control). 
 
4.3.4 SDS PAGE and western blotting 
 
4.3.4.1 Catechin-HSA systems: aggregation and cross-links formation 
SDS-PAGE was performed using discontinuous system with 4% stacking gel and 
7.5% separating non-denaturating gel. All lanes were loaded with 4 μg of protein. 
Electrophoresis was performed at 200 V using Mini ProteanIII apparatus (BioRad). Gels 
were visualized with colloidal Coomassie Blue G250, scanned, and their quantification 
was performed using Quantity One software (BioRad). 
 
4.3.4.2 MGO-mediated glycation of GST: AGEs and cross-links formation   
Formation of specific AGEs was assessed using western blotting with 
corresponding antibodies. Proteins were first separated by SDS PAGE on Mini 
ProteanIII apparatus (BioRad). SDS PAGE was performed using discontinuous system 
with 4% stacking gel and 12.5% separating gel according to the method of Laemmli 
[1970]. Lanes were loaded with 4 μg of protein. Proteins were then transferred to 
PVDF membrane (0.2 μm, Bio-Rad Laboratories, Hercules, USA) [Towbin et al. 1979] at 
a constant voltage of 100 V for 90 min (Mini Trans-Blot Electrophoretic Transfer Cell, 
Bio-Rad). After blotting, membranes were blocked in 8% non-fat dry milk in Tris 
buffered saline-Tween-20 buffer overnight at 4°C. After washing in Tris buffered saline-
Tween-20 buffer, the membranes were reacted with either primary rabbit anti-AGE 
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antibody (dilution 1:1000) or primary mouse anti-MGO [3C] antibody (1:1000) for 45 
min at room temperature. Subsequently, membranes were washed six times with Tris 
buffered saline-Tween-20 buffer and incubated with corresponding secondary 
antibody for 45 min (dilution 1:2000 for anti-rabbit IgG and 1:1000 for anti-mouse IgG). 
The blots were extensively washed in 0.1 M Tris buffer containing 5 mM MgCl2.6H2O 
(pH 9.5), covered with chemiluminescent substrate DuoLux and incubated for 5 min. 
Protein bands were then detected by both chemiluminescent detection and staining 
with Ponceau S. Membranes and X-ray films (CL-XPosure film, Thermo Fisher Scientific) 
were scanned on GelDoc XR system and quantified by Quantity One software (BioRad).  
 
4.3.5 Statistical analysis 
Obtained values are given as means ± standard deviation (n  5). Statistical 
significance was determined using Student’s t-test and differences were regarded as 
significant when p < 0.01 or p < 0.05. Details of each statistical analysis are 



















5 RESULTS AND DISCUSSION 
 
5.1 INTERACTION BETWEEN HYDROXYCINNAMIC ACIDS AND BOVINE SERUM 
ALBUMIN 
The possibility of binding of eight naturally occurring hydroxycinnamic acids 
(HCAs) to bovine serum albumin (BSA) has been studied using fluorescence quenching 
method under simulated physiological conditions (pH 7.4, 37°C) in the in vitro model. 
The main objective was to reveal the character of interactions and to evaluate the 
structure-binding activity relationships. The structures of the tested HCAs are shown in 
Table 2. 
 
5.1.1 Stability of hydroxycinnamic acids 
Firstly, stabilities of hydroxycinnamic acid solutions in phosphate buffer (0.1 M, pH 
7.4, 0.05% NaN3) during long-term incubation (28 days) at 37°C were checked by 
observation of changes in their characteristic UV-Vis absorption spectra (data not 
shown). No changes of absorbance in the characteristic profile of UV-Vis spectra of 
monosubstituted derivatives (coumaric acids) were observed during the incubation. 
Spectrum profile of ferulic acid was not altered throughout the incubation, but the 
intensity of absorbance in maximum slowly decreased. The spectra of other four 
tested derivatives (caffeic, sinapic, chlorogenic, and rosmarinic acid) showed 
remarkable changes which suggest that these compounds were decomposed probably 
to catechol and its substituted derivatives within first 24 hours of incubation [Müller et 
al. 2006, Jiang and Peterson 2010]. It can be concluded that coumaric acids are stable 
within the course of long term incubation, while di- and trisubstituted derivatives 
decompose easily and therefore they are not suitable for long lasting experiments. In 
the following experiment, the fluorimetric titration was carried out in phosphate 
buffer (0.1 M, pH 7.4, 0.05% sodium azide) during 45 minutes, where no changes in 




5.1.2 Fluorescence quenching spectra of BSA induced by hydroxycinnamic acids 
Quenching of protein intrinsic (tryptophan) fluorescence was employed for more 
detailed study of HCA-BSA binding. First of all, fluorescence emission spectra of 
individual HCAs were measured as blanks. Only three HCAs (o-coumaric, sinapic, and 
ferulic acid) possessed apparent emission maxima at 498, 428, and 414, respectively. 
The most remarkable fluorescence intensity exerted o-coumaric acid (Figure 10). 
Fluorescence intensity of BSA gradually decreased with increasing concentration 
of all HCAs (Figure 10). This may indicate alterations in microenvironment around 
tryptophan residues in protein molecule upon interaction with the tested compounds. 
Moreover, bathochromic (red) shifts of tryptophan emission maximum (350 nm) in 
dependence on increasing concentration of tested compounds were found in the case 
of ferulic, sinapic, chlorogenic, and rosmarinic acids. Emission maximum was slightly 
shifted towards longer wavelength by 2 nm for both ferulic and sinapic acid-BSA 
systems, and by 4 and 5 nm for chlorogenic and rosmarinic acid-BSA systems, 
respectively. 
The red shift of protein emission band is caused by decrease in hydrophobic 
property of binding cavity near tryptophan in BSA (Trp-212) suggesting that tryptophan 
has been brought to more hydrophilic environment and thus protein secondary 
structure has been changed [Lakowicz 2006, Kang et al. 2004]. Li et al. [2010] have 
noticed the obvious red shifts of ferulic and chlorogenic acid-BSA systems by 5 and 20 
nm under different conditions (e.g. temperature, pH, λex, 0 - 7 x 10
-5 M for HCAs), 
respectively. Significant red shifts by 12 and 18 nm were observed also by other 
authors upon interaction of HSA with sinapic [He et al. 2005] and chlorogenic [Kang et 
al. 2004] acids but the concentrations of tested compounds that caused so remarkable 
shift of emission maxima were as much as 1.5 x 10-4 M. Other four tested HCAs did not 
cause any spectral shift in the studied range of concentrations which indicates that 
they can bind to BSA without affecting the immediate environment of the tryptophan 
residues [Li et al. 2010, Tian et al. 2004b]. It can be concluded that red shift of protein 
emission band by HCAs depends on their structure, size and concentration. More 
pronounced red shift was noticed for bulkier molecules of HCAs such as chlorogenic or 
rosmarinic acids corresponding with the published data [Hu et al. 2012, Li et al. 2010]. 
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Emission quenching spectra of BSA induced by o-coumaric, caffeic, ferulic, and 
sinapic acids involved isosbestic point, which might indicate that studied compounds 
exist both in bound and free form that are in equilibrium [Li et al. 2010, Rawel et al. 
2006, Xie et al. 2006]. The bound form exerts fluorescence whereas the unbound form 
does not. It was noticed that emission spectra of these HCA-BSA systems above 430 




Figure 10: Fluorescence quenching spectra of HCA-BSA systems. 
[BSA] = 2 x 10-6 M, [HCA] = 0 - 2 x 10-5 M, [HCA]/[HSA] = 0.625, 1.25, 1.875, 2.5, 3.125, 
3.75, 4.375, and 5.00, pH 7.4, 37°C, and λex = 295 nm. Dotted line and arrow display 
fluorescence spectrum of hydroxycinnamic acid (2 x 10-5 M) and shift, respectively. 




5.1.3 Fluorescence quenching mechanism of hydroxycinnamic acid-BSA systems 
The Stern-Volmer analysis was applied for determination of the type of 
fluorescence quenching mechanism of the HCA-BSA systems. The relevant Stern-
Volmer plots (i.e. F0/F versus [Q]) are displayed in the Figure 11. The most significant 
quenching effect (about 82.7%) was caused by rosmarinic acid but it exhibited the 
exponential dependence indicating that both types of quenching were asserted. For 
this reason, the constants (KSV and Kq) were not determined. However, the linear 
dependence in the Stern-Volmer plots in the studied concentration range (0-2 x 10-5 
M) was found out for all other HCAs. Consequently, the Stern-Volmer quenching 
constants (KSV) and the bimolecular quenching rate constants (Kq) of these HCAs were 
determined from the slopes and are shown in Table 10. It was confirmed that the 
static quenching mechanism (i.e. non-fluorescent complex formation) is the main 
reason of protein fluorescence quenching because all Kq values were found to be 
higher than the diffusion-limited rate constant of a biomolecule (Kdiff = 1 x 10
10 M-1s-1) 
[Lakowicz 2006]. The highest value of Kq was determined for p-coumaric acid and 
further decreased in the order p-coumaric acid > m-coumaric acid ≥ o-coumaric acid > 





Table 10: The Stern-Volmer constants (KSV) and bimolecular quenching rate constants 
(Kq) of tested hydroxycinnamic-BSA systems (pH 7.4, 37°C). 
 
Tested compound KSV [10
4 M-1] Kq [10
13 M-1s-1 ] R 
o-Coumaric acid 5.95b 1.19b 0.995 
m-Coumaric acid 5.96b 1.19b 0.998 
p-Coumaric acid 7.13a 1.43a 0.993 
Caffeic acid 4.30e 0.86e 0.997 
Ferulic acid 4.86d 0.97d 0.996 
Sinapic acid 4.25f 0.85f 0.997 
Chlorogenic acid 5.36c 1.07c 0.997 
Rosmarinic acid - - - 
Kq = KSV/τ0; τ0 = 5 x 10
-9
 s [Lakowicz 2006]. Standard deviations (mean value of three independent 
experiments) were lower than 10%. Data were analyzed by Student´s t-test and groups with different 







Figure 11: Stern-Volmer plots of tested hydroxycinnamic acid-BSA systems.  
[BSA] = 2 x 10-6 M, [HCA] = 0 - 2 x 10-5 M, pH 7.4, 37°C, λex = 295 nm, and λem = 350 nm. 
Correlation coefficients (R) were found in the range of 0.993 - 0.998. 
 
 
Only small but significant differences among Kq values for the tested HCA-BSA 
systems were observed. All tested HCAs exerted better quenching effect than cinnamic 
acid (2.26 x 1012 M-1s-1 for τ = 10-8 s) [Bian et al. 2007]. Rosmarinic acid caused the 
most outstanding decrease in fluorescence intensity of BSA in the range of studied 
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concentrations but it exhibited exponential dependence in the Stern-Volmer diagram 
and thus was not considered in overall comparison. Coumaric acids showed stronger 
quenching activity than the other more substituted HCAs. In the case of coumaric 
acids, this effect was probably dependent upon the position of hydroxyl group on 
aromatic ring and p-position seems to be the most suitable structural feature for 
quenching fluorescence of BSA. The Kq value of chlorogenic acid was similar to Kq of 
coumaric acids and slightly higher than Kq of more substituted derivatives. It was 
probably caused by its spatial arrangement and the presence of aromatic ring and five 
hydroxyls in its molecule [Kang et al. 2004]. The lowest quenching effect was observed 
for sinapic and caffeic acid followed by ferulic acid. Presence of the methoxyl group in 
HCA seemed to play a role in quenching activity too. Ferulic acid showed higher effect 
than caffeic acid, while the Kq of sinapic acid was slightly lower compared to caffeic 
acid. This was perhaps caused by steric hindrance in the molecule of sinapic acid. The 
obtained bimolecular quenching rate constants for caffeic, ferulic, and chlorogenic 
acid-BSA systems are in good agreement with data found in literature [Hu et al. 2012, 
Liu et al. 2010, Tang et al. 2008a]. However, no quenching of BSA induced by 
chlorogenic acid was also observed [Rawel et al. 2006]. Several studies were published 
for HCA-HSA systems too. The highest Kq was obtained for chlorogenic acid followed by 
caffeic and sinapic, while ferulic and p-coumaric acid possessed lower Kq values. Data 
obtained for HCA-BSA systems in this study correspond with the findings published by 
other authors [Hu et al. 2012, Jiang et al. 2004, Kang et al. 2004]. 
 
5.1.4 Determination of binding parameters of hydroxycinnamic acid-BSA systems 
In general, the binding constant (Kb) reflects the power of ligand-protein 
association and thus can be used for comparison of binding affinities of structurally-
related ligands to protein molecule connected with alterations of its secondary 
structure. Number of binding sites (n) is another important parameter that contributes 
to better understanding of ligand-protein interaction [Lakowicz 2006]. 
Except for the rosmarinic acid-BSA system, the binding constants (Kb), number of 
binding sites (n), and free energy changes (∆G0) of all other HCA-BSA systems have 
been determined according to the equations (2) and (4), respectively. Obtained values 
are presented in Table 11. Logarithmic plots of the tested HCA-BSA systems are 
76 
 
displayed in Figure 12. The binding affinity was the strongest for chlorogenic acid and 
ranked in the order chlorogenic acid > sinapic acid > caffeic acid > ferulic acid ≥ o-
coumaric acid > p-coumaric acid > m-coumaric acid. The negative value of free 
enthalpy (∆G0) indicating spontaneous process of HCA-BSA binding was determined for 




Figure 12: Logarithmic plots of tested hydroxycinnamic acid-BSA systems.  
[BSA] = 2 x 10-6 M, [HCA] = 0 - 2 x 10-5 M, pH 7.4, 37°C, λex = 295 nm, and λem = 350 nm. 





Table 11: The binding constants (Kb), number of binding sites (n), and free energy 
change (∆G0) of tested hydroxycinnamic acid-BSA systems (pH 7.4, 37°C). 
 
Tested compound Kb [x10
5 M-1] n  R ΔG0 [kJ.mol-1] 
o-Coumaric acid 3.34b 1.17 0.997 -32.73ab 
m-Coumaric acid 1.31e 1.08 0.998 -30.36b 
p-Coumaric acid 1.81d 1.10 0.993 -30.98ab 
Caffeic acid 4.16c 1.18 0.995 -33.12a 
Ferulic acid 3.33b 1.18 0.994 -32.75ab 
Sinapic acid 4.19b 1.21 0.997 -33.36ab 
Chlorogenic acid 6.67a 1.23 0.998 -34.55a 
Standard deviations (mean value of three independent experiments) were found in the range of 3 - 40%. 
Data were analyzed by Student´s t-test and groups with different letters are significantly different (p < 
0.05). Differences in the number of binding sites were not statistically significant. 
 
The binding constant (Kb) for cinnamic acid-BSA system mentioned in the 
literature [Bian et al. 2007, He et al. 2010, Jiang et al. 2004] is lower than values 
obtained in our experiments for HCA-BSA systems, which may confirm significance of 
hydroxyl groups in the process of binding. Moreover, binding affinity of cinnamic acid 
is higher for BSA than for HSA, which indicates that also binding of HCAs to BSA may be 
more pronounced [Jiang et al. 2004]. The same result was noticed for chlorogenic acid-
HSA and chlorogenic acid-BSA systems using nuclear magnetic resonance (NMR) 
[Wang et al. 2011]. It was demonstrated that interaction of HCAs with protein 
molecule depends mainly on the ligand size and structure, especially on the number 
and position of hydroxyl groups on the aromatic ring *Rawel et al. 2006, Bartolomé et 
al. 2000]. Hydroxyl groups of studied compounds can form hydrogen bonds with amino 
acid residues in the protein molecule. Another important factor influencing ligand-
protein binding is aromaticity of the ligand molecule because hydrophobic interactions 
can be asserted between aromatic rings of ligand and aromatic amino acid residues of 
proteins [Liu et al. 2005]. Chlorogenic acid with two aromatic hydroxyls and three 
hydroxyls on cyclohexane ring exerted the strongest binding affinity towards BSA 
because it can from hydrogen bonds with protein more easily than other less-
substituted HCAs, e.g. ferulic acid. Thus esterification of carboxyl group with quinic 
acid increased this affinity. The similar results have been published for comparison of 
binding affinities of ferulic and chlorogenic acids towards BSA or HSA [He et al. 2010, 
Liu et al. 2010, Kang et al. 2004]. It is evident that the hydroxyls substituted on 
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aromatic ring of the HCAs play an important role in the binding affinity towards BSA. 
Monosubstituted HCAs possessed the lowest binding affinities of all HCAs studied. In 
the case of coumaric acids, the position of hydroxyl group on aromatic ring seems to 
play a role in binding affinity to BSA. The most suitable structural feature was 
determined o-position followed by p- and m-position. In comparison of caffeic, ferulic, 
and sinapic acids, it was noticed that substitution of hydroxyl on aromatic ring by 
methoxyl group lowered binding ability to BSA which is also supported by other 
authors [He et al. 2010, Liu et al. 2010]. 
The binding parameters of chlorogenic and ferulic acids with bovine serum 
albumin have been intensively studied. The value of Kb reported by Tang et al. [2008a] 
for chlorogenic acid-BSA system using fluorescence quenching method is lower than 
the value obtained in our experiments, which is probably due to different experimental 
conditions. Liu et al. [2010] compared binding affinity of caffeic, ferulic, and 
chlorogenic acids to BSA by fluorescence quenching method and their data are 
consistent with our results. However, Rawel et al. [2005, 2006] reported that 
chlorogenic acid does not quench tryptophan fluorescence of BSA and determined its 
binding constant by Hummel-Dreyer/size exclusion chromatography, which showed 
significantly lower Kb value in comparison with results presented by Tang et al. 
[2008a]. Non-covalent interactions of chlorogenic acid with BSA have been studied by 
Prigent et al. [2003], who reported that these interactions decrease with the increasing 
temperature, while pH and ionic strength had no pronounced effect. Zhang et al. 
[2007] reported the Kb for ferulic acid-BSA system determined by affinity capillary 
electrophoresis, which is in good agreement with our result. By contrast, Rawel et al. 
[2006] determined binding constant of ferulic acid-BSA system by fluorescence 
quenching method and Hummel-Dreyer/size exclusion chromatography, where first 
method gave similar results to our data and Kb obtained by second method was 
significantly lower. Several studies dealing with binding of p-coumaric, caffeic, ferulic, 
sinapic, and chlorogenic acids with HSA have been also published [Hu et al. 2012, Jiang 
et al. 2004, Kang et al. 2004, Liu et al. 2005].  
The results showed that the number of binding sites ranged between 1.08 and 
1.23 suggesting that one molecule of BSA was associated with one molecule of HCA in 
the drug to protein ratio up to 10 for the tested HCAs apart. The number of binding 
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sites rose with increasing number of hydroxyl groups in the ligand molecule, but their 
differences were not statistically significant. The similar results have been described in 
literature [He et al. 2010, Li et al. 2010]. 
The relatively strong binding enthalpy underlines the stability of HCA-BSA 
complexes from the energetic point of view. These findings are supported by data 
found in literature [Bian et al. 2007, He et al. 2010, Rawel et al. 2005, Rawel et al. 
2006]. 
Interactions of HCAs with BSA differed in their binding affinities depending on the 
ligand size and structure. Binding affinities of HCAs towards BSA increased with 
increasing number of hydroxyl groups in their molecules which is consistent with the 
published data [He et al. 2005, Liu et al. 2010]. Coumaric acids containing only one 
hydroxyl group showed the lowest binding affinity to BSA. Substitution of hydroxyl by 
methoxyl group lowered the binding affinity towards BSA, whereas esterification of 
carboxyl group with quinic acid increased this binding ability. Obtained results also 
showed that tryptophan residues in BSA are not equally accessible to individual HCAs. 
Number of binding sites depended upon concentration of HCA. Ligands first bind to 
Trp-134, which is located on the surface of protein. With increasing concentration of 
HCAs, the microenvironment of Trp-212 changes to more hydrophilic, which leads to 
alterations in protein structure and results in better accessibility of Trp-212 for 
interaction with ligand. 
 
 
5.2 INTERACTION BETWEEN CATECHINS  AND HUMAN SERUM ALBUMIN 
In this part, the binding affinity of eight naturally occurring catechins to HSA has 
been investigated in detail predominantly by fluorescence spectroscopy in 
combination with UV-Vis absorption spectroscopy and electrophoretic methods under 
simulated physiological conditions (pH 7.4, 37°C) in the in vitro models. The main 
objective was to reveal the character of interactions and consecutively to evaluate the 
relationships between the structure characteristics of the studied catechins (i.e. the 
presence of galloyl moiety on the C-ring, the number of hydroxyl groups on the B-ring, 
and the spatial arrangement of the substituents on the C-ring) and their binding 




Figure 13: Chemical structures of tested catechins. 
 
5.2.1 Stability of catechins 
As for hydroxycinnamic acids, stabilities of the catechin solutions in phosphate 
buffer (0.1 M, pH 7.4, 0.05% NaN3) were verified during long-term incubation (15 days) 
at 37°C by observation of changes in their characteristic UV-Vis absorption spectra. 
Slight changes in the spectra of all catechins appeared already after one hour of 
incubation and decomposition of the compounds significantly proceeded during 7 
following days (data not shown). The obtained data are consistent with literature 
[Mochizuki et al. 2002, Roginsky and Alegria 2005, Sang et al. 2005]. Since the time-
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dependent solution instabilities can influence the results of interaction between HSA 
and tested compounds in phosphate buffer (pH 7.4), the spectroscopic and 
fluorimetric measurements were carried out up to 30 minutes.  
In addition, protection of (-)-epigallocatechin gallate by the sulfhydryl group of 
HSA (Cys-34), which act as an antioxidant, against its oxidation under aerobic 
conditions has been described [Bae et al. 2009]. The similar effect may be expected 
also for some other flavonoids. On the other hand, catechins can cause protein 
carbonyl formation in HSA via their pro-oxidant action [Ishi et al. 2010b].  
 
5.2.2 Complex formation between catechins and HSA 
In the present study, the absorption spectra of HSA in the absence and presence 
of individual catechins were recorded after 5 min of interaction. No changes were 
noticed in absorption spectra of HSA after interaction with catechins lacking the galloyl 
moiety on the C-ring (C, EC, GC, and EGC). On the other hand, the obvious changes, 
such as slight decrease of absorbance between 200 and 280 nm, significant growth of 
absorbance between 300 and 360 nm (λmax = 330 nm) and slight red shift, in 
absorption spectrum of HSA after addition of the galloylated catechins (Cg, ECg, GCg, 
and EGCg) confirmed the complex formation [Guo et al. 2009]. The differential 
absorption spectra of HSA before and after interaction with epicatechin gallate are 
displayed in Figure 14.  
 
Figure 14: UV-Vis absorption spectra of HSA before and after interaction with 




It can be concluded that the presence of galloyl group in the molecules of 
catechins is responsible for their complex formation with HSA. It was not possible to 
gain more detailed information because UV-Vis absorption spectroscopy represents 
less sensitive technique. 
 
5.2.3 Fluorescence spectra of catechins and catechin-HSA systems 
As was described above, the complex formations between HSA and catechin 
gallates were noticed upon analyzing their UV-Vis absorption spectra. Subsequently, 
the emission spectra of these complexes were recorded with the excitation at 330 nm, 
which corresponds with the observed absorption maximum. All complexes emitted 
light between 374 and 377 nm (Figure 15), whereas catechin gallates as well as other 
catechins alone were not emissive under these experimental conditions. 
 
Figure 15: Fluorescence emission spectra of complex formation between catechin 
gallates and HSA. [HSA] = 4 x 10-6 M, [catechin gallate] = 4 x 10-5 M, pH 7.4, 37°C, λex = 
330 nm, and 5 min of interaction. 
 
Fluorescence emission spectra of individual catechins were recorded at excitation 
wavelength of 295 nm, which corresponds to the tryptophan residue (Figure 16). Only, 
catechin and epicatechin possessed intrinsic fluorescence and both displayed the 
similar spectra with emission maximum of 318 nm. The observed wavelength of their 
emission maximum is consistent with literature [Papadopoulou et al. 2005]. Other 




5.2.4 Fluorescence quenching spectra of HSA induced by catechins 
Quenching of protein intrinsic (tryptophan) fluorescence was employed for more 
detailed study of catechin-HSA interactions. Fluorescence intensity of HSA was 
gradually decreased with rising concentration of all tested compounds. All catechin 
gallates (Cg, ECg, GCg, and EGCg) caused more pronounced decrease in the tryptophan 
fluorescence of the HSA emission maximum (348 nm) than other catechins (C, EC, GC, 
and EGC). Furthermore, remarkable red shifts in their fluorescence quenching spectra 
were observed (Figure 16). Emission maximum of HSA was shifted towards longer 
wavelength by 25 nm for both catechin gallate-HSA and epicatechin gallate-HSA 
system, and by 23 nm for gallocatechin gallate-HSA system as well as for 
epigallocatechin gallate-HSA system. Generally, red shift in the emission maximum of a 
tryptophan residue, which is located in a hydrophobic pocket, indicates changes in its 
microenvironment, i.e. a polypeptide strand of a protein molecule is more extended 
and the hydrophobicity around this tryptophan residue is decreased [Lakowicz 2006]. 
These data suggest that Trp-214, which is the sole tryptophan residue in the HSA 
molecule, has been brought to a more hydrophilic environment and the protein 
secondary structure has been changed. No shifts in the emission maximum of HSA 
were observed after gradual additions of the non-galloylated catechins. Red shift in the 
fluorescence quenching spectra of (-)-epigallocatechin gallate-HSA system was also 
reported [Maiti et al. 2006]. By contrast, no shifts in the emission spectra of bovine 
serum albumin after titration with increasing amounts of (+)-catechin, (-)-epicatechin, 
and (-)-epicatechin gallate were noticed [Papadopoulou et al. 2005, Soares et al. 2007]. 





Figure 16: Fluorescence quenching spectra of catechin-HSA systems. 
[HSA] = 4 x 10-6 M, [catechin] = 0 - 2 x 10-5 M, [non-galloylated catechin]/[HSA] = 0, 1, 
2, 3, 4, and 5; [galloylated catechin]/[HSA] = 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, and 5; 
pH 7.4, 37°C, and λex = 295 nm. Dotted line and horizontal arrow display fluorescence 




5.2.5 Fluorescence quenching mechanism of catechin-HSA systems 
In order to clarify the fluorescence quenching mechanism induced by individual 
catechins, the fluorescence quenching data were analyzed using the Stern-Volmer 
analysis [Lakowicz 2006]. Fluorescence intensities were read at emission wavelength of 
348 nm where the emission maximum of HSA was located. The Stern-Volmer plots 
(F0/F versus [Q]) were linear in the range of studied concentrations (0 - 2 x 10
-5 M) for 
all tested systems and the Stern-Volmer constants (KSV) and consecutively the 
bimolecular quenching rate constants (Kq) were determined from their slopes (Figure 
17). Values of the above mentioned constants are summarized in the Table 12.  
The bimolecular quenching constant (Kq) reflects an efficiency of quenching or an 
accessibility of the fluorophores to a quencher. One of the criterions for determination 
of a static quenching mechanism is that the value of Kq is higher than the value of a 
diffusion-limited rate constant of a biomolecule (Kdiff = 1.0 x 10
10 M-1s-1) [Lakowicz 
2006]. The values of Kq for all tested systems were higher that of Kdiff, which confirmed 
that the static quenching mechanism is likely the main reason of protein fluorescence 
quenching [Lakowicz 2006]. The highest value of Kq was determined for epicatechin 
gallate and further decreased in the order ECg > Cg ≥ EGCg ≥ GCg >> EC ≥ C > GC > EGC.  
 
 
Figure 17: Stern-Volmer plots of tested catechin-HSA systems.  
[HSA] = 4 x 10-6 M, [catechin] = 0 - 2 x 10-5 M, pH 7.4, 37°C, λex = 295 nm, and λem = 348 
nm. Correlation coefficients (R) were found in the range of 0.992 - 0.999. 
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Table 12: The Stern-Volmer constants (KSV) and bimolecular quenching rate constants 
(Kq) of tested catechin-HSA systems (pH 7.4, 37°C). 
 
Tested compound KSV [10
4 M-1] Kq [10
12 M-1s-1 ] R 
Catechin 1.07c 2.15c 0.992 
Epicatechin 1.22c 2.44c 0.995 
Gallocatechin 0.55b 1.10b 0.989 
Epigallocatechin 0.42a 0.84a 0.993 
Catechin gallate 8.12de 16.25de 0.996 
Epicatechin gallate 9.63e 19.26e 0.999 
Gallocatechin gallate 6.66d 13.33d 0.995 
Epigallocatechin gallate 7.32d 14.65d 0.995 
Kq = KSV/τ0; τ0 = 5 x 10
-9
 s [Lakowicz 2006]. Correlation coefficients (R) were higher than 0.990. Standard 
deviations (mean value of three independent experiments) were lower than 10%. Data were analyzed 
by Student´s t-test and groups with different letters are significantly different (p < 0.01). 
 
The importance of the presence of the galloyl moiety on the C-ring was evident 
because quenching constants for all catechin gallates (Cg, ECg, GCg, and EGCg) were 
significantly higher than those of catechins lacking the galloyl group (C, EC, GC, and 
EGC). Catechin gallates with 2,3-cis structure (ECg and EGCg) possessed greater Kq 
values than catechin gallates with 2,3-trans-structure (Cg and GCg). Catechins with the 
catechol group on the B-ring (C, EC, ECg, and Cg) showed more pronounced quenching 
effect than their analogs with pyrogallol moiety (GC, EGC, EGCg, and GCg). 
 
5.2.6 Determination of binding parameters of catechin-HSA systems 
In general, a binding constant Kb reflects the power of ligand-protein association 
and thus can be used for comparison of the binding affinities of structurally-related 
ligands to a protein molecule connected with the alterations in its secondary structure. 
Number of binding sites (n) and free energy change (ΔG0) are other important 
parameters that contribute to better understanding of ligand-protein interactions 
[Lakowicz 2006, Bi et al. 2004].  
In this case, the binding constants (Kb), binding sites (n), and free energy changes 
(∆G0) of all catechin-HSA systems have been determined according to the equations (3) 
and (4). The obtained values are presented in Table 13 and the logarithmic plots for 
determination of binding parameters are displayed in Figure 18. The binding affinity 
was the strongest for epicatechin gallate and decreased in the order ECg ≥ Cg > EGCg ≥ 
GCg >> EC ≥ C > GC ≥ EGC. The non-galloylated catechins possessed significantly lower 
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binding constants. The value of the number of binding sites (n) ranged from 0.87 to 
1.10. Negative values of free energy changes (ΔG0) for all studied interactions indicate 
that the binding between HSA and individual catechins proceeds spontaneously. 
 
Figure 18: Logarithmic plots of studied catechin-HSA systems.  
[HSA] = 4 x 10-6 M, [catechin] = 0 - 2 x 10-5 M, pH 7.4, 37°C, λex = 295 nm, and λem = 348 
nm. Correlation coefficients (R) were found in the range 0.993 - 0.999. 
 
Table 13: The binding constants (Kb), number of binding sites (n) and free energy 
change (∆G0) of tested catechin-HSA systems (pH 7.4, 37°C). 
 
Tested compound Kb [x10
4 M-1] n  R ΔG0 [kJ.mol-1] 
Catechin 1.10b 1.00 0.997 -23.99b 
Epicatechin 1.12b 0.91 0.998 -24.03b 
Gallocatechin 0.43a 0.87 0.993 -21.54a 
Epigallocatechin 0.34a 0.89 0.994 -20.93a 
Catechin gallate 9.21de  1.01 0.999 -29.46de 
Epicatechin gallate 10.57e 0.97 0.996 -29.82e 
Gallocatechin gallate 6.75c 1.10 0.998 -28.66c  
Epigallocatechin gallate 7.79d 1.03 0.997 -29.03d 
Standard deviations (mean value of three independent experiments) were lower than 10%. Data were 
analyzed by Student´s t-test and groups with different letters are significantly different (p < 0.01). 
Differences in the number of binding sites were not statistically significant. 
 
In general, the hydrophobicity, presence or absence of some functional group, 
steric hindrance, and spatial arrangement seem to be the key factors in the affinity of 
natural polyphenols towards plasmatic proteins [Diniz et al. 2008, Ishii et al. 2010a]. 
These compounds probably form reversible non-covalent complexes with the molecule 
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of serum albumin mainly through hydrogen bonding of their hydroxyl groups with 
amino acid residues and hydrophobic interactions between their aromatic rings and 
amino acid residues in the protein chain [Diniz et al. 2008, Otagiri 2005]. 
The galloylated catechins (Cg, ECg, GCg, and EGCg) showed significantly higher 
binding ability than the non-galloylated catechins (C, EC, GC, and EGC). It confirmed 
the importance of the galloyl moiety on the C-ring in the binding affinity of catechins 
to HSA due to a presence of additional aromatic ring with three hydroxyl groups, which 
can establish hydrophobic interactions and hydrogen bonds, respectively. The effect of 
this structural feature was clearly underlined by all applied methods. Also data found 
in literature support these findings, e.g. Ishii et al. [2010a] who studied binding 
affinities of catechins to the HSA with respect to their structural features using high-
performance affinity chromatography with immobilized albumin column. 
In addition, catechol-type catechins (ECg ≥ Cg > EC ≥ C) possessed stronger binding 
affinity than pyrogallol-type catechins (EGCg > GCg > GC > EGC). It suggests that the 
insertion of an additional hydroxyl group at the 5-position on the B-ring did not 
contribute to their binding affinities in the experimental model used, which is in 
conflict with literature data [Ishii et al. 2010a]. The effect of the spatial arrangement of 
catechins (i.e. cis- and trans-structure) on the binding to HSA was not explicit. Ishii et 
al. [2010a] observed that the trans-type catechins (C, GC, Cg, and GCg) had rather 
higher binding abilities than their epimers (EC, EGC, ECg, and EGCg). In this study, the 
opposite effect was observed in the case of the galloylated catechins. Diniz et al. 
[2008] found out using capillary electrophoresis that (-)-epicatechin showed no affinity 
towards HSA whilst (+)-catechin had intermediate binding ability to HSA (Kb = 2.2 x 10
3 
M-1 and n = 1), which the authors attributed to the spatial arrangement of tested 
catechins. Ishii et al. [2010a] noticed negligible differences in binding affinities among 
(+)-catechin, (-)-catechin, and (-)-epicatechin obtained by affinity HPLC on immobilized 
HSA column. The latter results well correspond with our data where insignificant 
difference between binding constants of (-)-catechin and (-)-epicatechin was observed. 
One of the most studied flavan-3-ols is (-)-epigallocatechin gallate and the results 
obtained by Maiti et al. [2006] for the system EGCg-HSA are in good agreement with 
our data although the experimental conditions were slightly different. Binding of (-)-
89 
 
epigallocatechin gallate to serum albumins was also studied in detail also by circular 
dichroism [Nozaki et al. 2009]. 
Further factor, which could contribute to binding affinity of tested catechins to 
HSA, is deprotonation of hydroxyl groups in their molecules. It is supposed that the 
catechins lacking the galloyl moiety (C, EC, GC, and EGC) are fully protonated at the 
tested pH (i.e. pH 7.4) because their first dissociation constants reach higher values 
(about pH 9) [Herrero-Martínez et al. 2005, Muzolf et al. 2008]. On the other hand, 
catechins with the galloyl moiety in C-ring (Cg, ECg, GCg, and EGCg) have the first 
dissociation constants near pH 7.4 [Muzolf et al. 2008], thus partial deprotonation can 
play role in the increase of their binding affinity to HSA. 
Number of binding sites determined for catechin-HSA systems ranged from 0.87 
to 1.10 suggesting that one molecule of HSA is associated with one molecule of 
catechin in the drug to protein ratio up to 5:1. The spontaneity of HSA-catechin 
interactions was confirmed by the negative values of ΔG0. These findings are 
supported by the previous report [Maiti et al. 2006]. 
 
5.2.7 Estimation of distances between catechins and HSA 
 The distances between Trp-214 in molecule of HSA (donor) and the catechins 
(acceptor) were estimated by fluorescence resonance energy transfer (FRET) method. 
The overlaps of the UV-Vis absorption spectra of individual catechins with the 
fluorescence spectrum of HSA occurred for all tested systems. There was noticed 
significant effect of the galloyl moiety on the extent of spectral overlapping. The 
galloylated catechins (Cg, ECg, GCg, and EGCg) caused much greater spectral overlap 
than the non-galloylated catechins (C, EC, GC, and EGC) (Figure 19). In the present 
case, k2 =2/3, N = 1.336, Ф = 0.118 [Yuan et al. 2007], the values of J, E, R0, and r0 for 
the tested systems have been calcuated according to the equations (5) - (7). The 






Figure 19: Spectral overlaps between the fluorescence emission spectrum of HSA and 
the absorption specra of catechins. [HSA] = [catechin] = 4 x 10-6 M, pH 7.4, 37°C, and 
λex = 295 nm. 
 
Table 14: The overlap integral (J), efficiency of energy transfer (E), critical distance 
(R0), and distance between donor (HSA) and acceptor (catechin) (r0) (pH 7.4, 37°C). 
 
Tested compound J [x 10-16 cm3.l.mol-1] E R0 [nm] r0 [nm] 
Catechin 0.40c 0.18b 0.98bc 1.26a 
Epicatechin 0.44bc 0.20c 0.99c 1.25a 
Gallocatechin 0.16ab 0.11a 0.84ab 1.19a 
Epigallocatechin 0.12a 0.08a 0.80a 1.20a 
Catechin gallate 26.04de 0.61de 1.96d 1.82b 
Epicatechin gallate 28.15e 0.66e 1.98d 1.78b 
Gallocatechin gallate 25.80de 0.57d  1.96d 1.85b 
Epigallocatechin gallate 22.00d 0.60d  1.91d 1.78b 
Standard deviations (mean value of three independent experiments) were lower than 10%. Data were 
analyzed by Student´s t-test and groups with different letters are significantly different (p < 0.01).  
 
 All binding distances (r0) were much lower than 8 nm, and fulfilled the following 
condition 0.5R0 < r0 < 1.5R0, which indicates that non-radiation energy transfer from 
HSA to catechins occurred with high probability [Guo et al. 2009]. The galloyl moiety in 
the C-ring proved to have significant effect on the extent of spectral overlapping as 
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was described in literature for catechin-HSA systems using high-performance affinity 
chromatography with immobilized albumin column [Ishii et al. 2010a]. 
 
5.2.8 Effect of catechins on molecular charge of HSA 
Native PAGE was used to investigate the changes in the molecular charge of HSA 
due to interactions with the catechins (Figure 20). The results were expressed as 
increment in electrophoretic mobility of individual samples compared to the native 
protein (control). The changes in the HSA molecule were exerted as broadening of 
protein band as well as increased sample mobility towards anode, which indicated that 
the molecule of HSA became more anionic due to the interaction with catechin gallates 
(Cg, ECg, GCg, EGCg). On the other hand, the non-galloylated catechins (C, EC, GC, and 
EGC) caused no significant changes in electrophoretic mobility of HSA. The 
electrophoretic mobility of tested systems decreased in the following order: EGCg 
(6.25%) > GCg (5.05%) > ECg (3.61%) > Cg (3.37%) ≈ EC (3.13%) > C (1.53%) ≥ GC 
(0.51%) ≈ EGC (0.24%).  
 
Figure 20: Effect of selected catechins on a molecular charge of HSA. [HSA] = 15 x 10-6 
M, [catechin] = 6 x 10-4 M. Samples were incubated for 30 minutes at 37°C.  
Electrophoretic mobilities were expressed as a rise in percentage mobility compared to 




The loss of positive charges in HSA molecule was in a good agreement with a 
number of hydroxyl groups and molecular weight of the galloylated catechins. 
Moreover, catechin gallates with the pyrogallol group on the B-ring (GCg and EGCg) 
showed more pronounced effect on mobility than catechin gallates with the catechol 
moiety (Cg and ECg). The similar results were described for (+)-catechin-BSA and 
epigallocatechin gallate-BSA systems [Kusuda et al. 2006]. 
 
5.2.9 Protein cross-linking and aggregation induced by catechins 
SDS PAGE analysis can provide some information on the binding stability and 
strength of the macromolecular complexes formed between serum albumin and plant 
polyphenols. The ability of aggregation and cross-link formation between the studied 
catechins and HSA was not proved by this method. No formation of high molecular 
weight protein adducts was observed (data not shown).  
The same result was obtained for (+)-catechin-BSA system. By contrast, the 
formation of water-soluble, macromolecular complex of (-)-epigallocatechin gallate-
BSA system has been proved by SDS PAGE after the incubation of 24 hours. It was also 
considered that the oxidation of (-)-epigallocatechin gallate contributes to its complex 
formation with BSA [Kusuda et al. 2006]. 
 
 
5.3 INTERACTION BETWEEN GREEN TEA CATECHINS AND ERP57 PROTEIN 
Revelation of ERp57 conformation changes induced by GTCs, namely epicatechin, 
epigallocatechin, epicatechin gallate, epigallocatechin gallate (Figure 12), and 
evaluation of their binding affinities to the studied protein in its reducing state were 
explored using fluorescence quenching method in the in vitro model (pH 7.4, 25°C). 
The effect of tested catechins on disulfide reductase activity of ERp57 has been 
investigated by sensitive fluorescent method. The structure-binding and structure-
activity relationships of GTCs were assessed. 
 
5.3.1 Fluorescence quenching spectra of ERp57 induced by green tea catechins 
Fluorescence quenching of protein intrinsic (tryptophan) fluorescence was 
employed for evaluation of ERp57 conformational changes induced by GTCs and for 
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detailed study of the GTC-ERp57 interactions. ERp57 possesses three tryptophan 
residues in its molecule differing in accessibility of a quencher to its molecule and thus 
unequally contributing to the protein intrinsic fluorescence. One tryptophan residue is 
buried in a hydrophobic pocket in the b´domain whereas the other two are located on 
the protein surface close to active thioredoxin-like sites in domains a and a´, 
respectively. ERp57 was reduced using dithiothreitol (DTT), which is used to reduce 
disulfide bonds of proteins, and thus to prevent formation of intramolecular and 
intermolecular disulfide bonds between cysteine residues of ERp57 in its redox active 
sites. 
The tryptophan fluorescence emission of ERp57 was significantly decreased only 
with rising concentration of the galloylated GTCs (Figure 21). Quenching effect of GTCs 
on ERp57 was determinated using equation (8) (Table 15) and reached 27.1 and 26.1% 
at the highest concentration of ECg and EGCg, respectively. Also slight red shifts were 
noticed in the case of ECg and EGCg-ERp57 systems.  
 
 
Figure 21: Fluorescence quenching spectra of GTC-ERp57 systems.  
[ERp57] = 5 x 10-7 M, [GTC] = 0 - 2 x 10-5 M, [non-galloylated GTC]/[ERp57] = 0, 8, 16, 
24, 32, and 40; [galloylated GTC]/[ERp57] = 0, 4, 8, 12, 16, 20, 24, 28, 32, 36, and 40; 





The obtained results indicates that the presence of galloyl moiety in molecule of 
GTCs plays an important role in their binding affinity to ERp57 and the galloylated GTCs 
are able to evoke slight changes in the protein secondary structure. 
 
5.3.2 Determination of binding parameters of green tea catechin-ERp57 systems 
The obtained fluorescence quenching data were analyzed in the same way as in 
the previous chapter dealing with catechin-HSA interactions. The Stern-Volmer analysis 
was used only for the galloylated GTC-ERp57 systems where significant quenching 
effect has been remarked. Fluorescence intensities were read at emission maximum 
wavelength of 338 nm. The Stern-Volmer plots were linear in the range of studied 
concentrations (0-2 x 10-5 M) (Figure 22) and the Stern-Volmer constants were 
obtained from equation (1). Also the binding constants (Kb), number of binding sites 
(n), and free energy changes (ΔG0) of the galloylated GTC-ERp57 systems were 
determined according to the equations (3) and (4) (Figure 23). The obtained values are 
summarized in Table 15. 
 
 
Figure 22: Stern-Volmer plots of galloylated GTC-ERp57 systems.  
[ERp57] = 5 x 10-7 M, [GTC] = 0 - 2 x 10-5 M, pH7.4, 25°C, λex = 290 nm, and λem = 338 
nm. Correlation coefficients were better than 0.997. Plots are displayed as means 





Figure 23: Logarithmic plots of galloylated GTC-ERp57 systems.  
[ERp57] = 5 x 10-7 M, [GTC] = 0 - 2 x 10-5 M, pH7.4, 25°C, λex = 290 nm, and λem = 338 
nm. Correlation coefficients were better than 0.997. Plots are displayed as means 
(three independent experiments) and standard deviations were better than 10%. 
 
Table 15: Fluorescence quenching effects of GTCs on ERp57 (Q), Stern-Volmer 
constants (KSV), number of binding sites (n), binding constants (Kb), and free energy 
change (∆G0) of tested systems (pH 7.4, 25°C). 
Tested system Q (%) Ksv (M
-1) n  Kb (M
-1) ∆G0 (kJ.mol-1) 
ERp57 + EC 6.65b - - - - 
ERp57 + EGC 4.35a - - - - 
ERp57 + ECg 27.13c 25647a 0.961 24063a -24.99a 
ERp57 + EGCg 26.07c 29219a 1.023 28650b -25.43a 
ERp57:GTC = 1:40. Standard deviations were lower than 10%. Data were analyzed by Student´s t-test 
and groups with different letters are significantly different (p < 0.05). Differences in the number of 
binding sites were not statistically significant. 
 
The obtained data confirmed that the galloyl moiety in molecule of GTCs is the 
important structural feature which significantly contributes to the binding affinity of 
GTCs to ERp57. The number of hydroxyl groups in the galloylated GTCs does not seem 
to play any role in their binding capability to the tested protein (differences are not 
statistically significant). The results well correspond with the data obtained by us and 
other authors dealing with interaction between catechins and human serum albumin 
[Ishii et al. 2010a]. Higher binding affinities of several antibiotics (e.g. vancomycin, 
streptomycin) to ERp57 have been already described [Gaucci et al. 2008].  
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5.3.3 Effect of green tea catechins on disulfide reductase  activity of ERp57 
Disulfide reductase activity of ERp57 was monitored by sensitive fluorescent assay 
using fluorogenic probe, dieosin glutathione disulfide (Di-E-GSSG) [Raturi and Mutus 
2007]. This probe displays low fluorescence (λex = 520 nm and λem = 545 nm) which 
significantly increased (approximately 70-fold) on reduction of its disulfide bond. Effect 
of green tea catechins (GTCs), N-ethylmaleimide (NEM) and vancomycin (VM) on 
reduction of Di-E-GSSG by reduced enzyme of ERp57 was investigated. Bovine serum 
albumin was used as negative control (blank). Linear increase of fluorescence of the 
probe during the defined time interval was found for all tested systems. The slopes 




Figure 24: Effect of green tea catechins on disulfide reductase activity of ERp57. 
[ERp57] = 1 x 10-6 M, [NEM] = 4 x 10-3 M, [VM] = 1 x 10-4 M, and [GTC] = 1 x 10-4 M. 
Samples were incubated for 15 minutes at 25°C. Standard deviations (mean value of 
six independent experiments) were lower than 11%. Data were analyzed by Student´s 




Disulfide reductase activity of ERp57 in the presence of green tea catechins was 
determined as 100.9%, 84.9%, 83.8%, and 84.8% for epicatechin, epigallocatechin, 
epicatechin gallate, and epigallocatechin gallate in comparison with ERp57 activity 
alone (100%), respectively. The three last mentioned catechins decreased the 
reductase activity of ERp57 by 15% (differences were not statistically significant), 
whilst epicatechin did not. The studied catechins except epicatechin had the similar 
decreasing effect on reductase activity of the protein as vancomycin (15.1%, not 
statistically significant), the antibiotic which binds to ERp57 and moderately inhibits its 
reductase activity [Gaucci et al. 2008]. All green tea catechins possessed much less 
pronounced effect in comparison with NEM (53.8%, statistically significant), the agent 
used for inhibition of cysteine residues in proteins. BSA did not show any disulfide 
reductase activity. The obtained results show that apart from epicatechin, all studied 
GTCs are able to reduce disulfide reductase activity of ERp57. Besides these natural 
compounds, also several antibiotics (e.g. vancomycin, erythromycin, or streptomycin) 
can lower the disulfide reductase activity of ERp57 [Gaucci et al. 2008]. 
 
 
5.4 EFFECT OF GREEN TEA CATECHINS ON METHYLGLYOXAL-MEDIATED GLYCATION 
OF HUMAN SERUM ALBUMIN 
Green tea catechins (GTCs), especially (-)-EGCg, have attracted a great attention in 
last two decades due to their beneficial effects on living organisms. The potential 
inhibitory activities of GTCs on MGO-mediated glycation of HSA were assessed by 
determination of AGEs with fluorescent properties.  Figure 25 displays courses of 
fluorescence emission spectra of total (“non-specific”) fluorescent AGEs (λex = 330 nm) 
and argpyrimidine (λex = 320 nm) formation during MGO-mediated glycation of HSA in 
the absence and presence of different EGCg concentrations. The obvious anti-glycating 
effect was noticed for EGCg in the concentration range of 0.01 - 0.05 mM in the case of 
total fluorescent AGEs formation (A), whereas only the highest EGCg concentration 









Figure 25: Fluorescence spectra of total fluorescent AGEs (A) and argpyrimidine (B) 
formation after incubation of HSA with MGO in the absence and presence of 
different EGCg concentrations. [HSA] = 1 mg/ml, [MGO] = 1 mM, [EGCg] = 0.001 - 







The effects of different GTCs concentrations on the formation of “non-specific” 
fluorescent AGEs are shown in Figure 26 and the obtained results (% inhibition of AGEs 
formation) are summarized in Table 16. The samples containing HSA and MGO exerted 
about 66.0% and 116.5% higher fluorescence intensity than the control sample 
without MGO after 3 and 7 days of incubation, respectively. Aminoguanidine (1.0 mM) 
and Trolox (2.5 mM) were used as positive controls. They reached obvious inhibitory 
effect on MGO-mediated glycation of HSA among 62.6 - 66.6% and 16.3 - 25.4%, 
respectively. All tested GTCs did not cause any significant decline in AGEs formation at 
the lowest concentration (0.010 mM). Epicatechin exhibited anti-glycating effect only 
at its highest concentration (0.050 mM) after 3 days of incubation (about 20%). Other 
GTCs (0.025 and 0.050 mM) showed more pronounced inhibition after 3 days of 
incubation than after 7 days. The galloylated GTCs (ECg and EGCg) demonstrated the 
similiar decrease in the AGEs formation and showed more significant anti-glycating 
effect than the non-galloylated GTCs and Trolox (2.5 mM). 
The effects of GTCs on the argpyrimidine formation during MGO-mediated 
glycation of HSA are displayed in Figure 27 and the obtained results (% inhibition of 
argpyrimidin formation) are given in Table 16. Methylglyoxal caused low but 
statistically significant increase in concentration of agrpyrimidine with fluorescent 
properties (by 11%) compared to the control sample (HSA alone). The non-galloylated 
GTCs (EC and EGC) exhibited no anti-glycating effect as well as the galloylated GTCs 
(ECg and EGCg) at concetrations of 0.010 and 0.025 mM. More pronounced inhbition 
of argpyrimidine formation was noticed in the case of the galloylated GTCs at 
concentration of 0.050 mM. It was reduced by 38% and 25% for ECg and EGCg, 
respectively, and higher inhibitory effect was noticed after 3 days of incubation than 
after 7 days. Aminoguanidine (1.0 mM) and Trolox (2.5 mM) reached anti-glycating 














Figure 26: Inhibitory effect of GTCs on total fluorescent AGEs formation during MGO-
mediated glycation of HSA (pH 7.4, 37°C). [HSA] = 1 mg/ml, [MGO] = 1 mM, λex = 330 
nm, and λem = 410 nm. The first and second columns represent inhibitory effects after 
3 and 7 days of incubation time, respectively. Standard deviations were lower than 
10%. Data were analyzed by Student´s t-test and groups with different letters are 










Figure 27: Inhibitory effect of GTCs on argpyrimidine formation during MGO-
mediated glycation of HSA (pH 7.4, 37°C). *HSA+ = 1 mg/ml, *MGO+ = 1 mM, λex = 320 
nm, and λem = 380 nm. The first and second columns represent inhibitory effects after 
incubation of 3 and 7 days, respectively. Standard deviations were lower than 10%. 
Data were analyzed by Student´s t-test and groups with different letters are 






Tables 16: Inhibitory effect of green tea catechins on total fluorescent AGEs and 
argpyrimidine formation during MGO-mediated glycation (pH 7.4, 37°C). [HSA] = 1 
mg/ml and [MGO+ = 1 mM, λex/λem = 330/410 nm (fluorescent AGEs), and λex/λem = 
320/380 nm (argpyrimidine). 
 
Compounds Concentration 
(x 10-3 M) 
% inhibition of total 
AGEs formation 
% inhibition of 
argpyrimidine formation 
3 days 7 days 3 days 7 days 
Epicatechin 0.010 -3.58 -2.93 -1.23 -2.87 
0.025 0.37 -3.19 -1.16 -2.25 
0.050 19.6 -0.52 3.87 3.11 
Epigallocatechin 0.010 2.58 -1.50 3.65 2.78 
0.025 25.8 9.18 7.09 6.91 
0.050 32.3 17.6 12.2 11.5 
Epicatechin  
gallate 
0.010 -0.29 -1.36 9.66 6.22 
0.025 45.7 19.5 22.9 20.4 
0.050 83.4 37.4 39.6 36.2 
Epigallocatechin 
gallate 
0.010 -1.36 7.61 4.74 1.29 
0.025 39.0 28.7 17.3 16.9 
0.050 76.61 40.8 28.5 20.6 
Aminoguanidine 1.0 62.6 66.6 64.5 63.7 
Trolox 2.5 16.3 25.4 13.1 15.0 
 
 
The anti-glycating effects of green tea catechins on middle stage of protein 
glycation were investigated using the in vitro model system containing human serum 
albumin as a model protein, methylglyoxal as a glycating agent, and GTCs as studied 
compounds with potential anti-glycating properties. Serum albumin belongs to the 
most used model proteins for assessment of anti-glycating activity of various 
compounds [Lunceford and Gugliucci 2005, Tsuji-Naito et al. 2009]. Methylglyoxal 
represents one of the reactive α-dicarbonyls, which are important precursors in the 
formation of AGEs in vivo, and are far more reactive than the parent sugars concerning 
their abilities to form inter- and intramolecular protein cross-links [Nass et al. 2007, 
Yim et al. 2001]. The increased levels of MGO have been reported in patients suffering 
from diabetes mellitus [McLellan et al. 1994]. This compound reacts irreversibly with 
lysine and arginine residues to form N-ε-(1-carboxyethyl)lysine (CEL), 1,3- di(N-ε-
lysino)-4-methyl-imidazolium (MOLD), argpyrimidine, and three structural isomers of 
hydroimidazolone [Ahmed et al. 2003]. One of the approaches in diabetes prevention 
or treatment is to develop effective compounds in removing α-dicarbonyls, and thus 
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forestall formation of AGEs. Aminoguanidine could serve as a prototype of such drugs 
because of its antioxidant and anti-glycating properties. However, its side adverse 
effects on human body have been indicated [Thornalley 2003]. Trolox is a water-
soluble derivative of vitamin E which shows also inhibitory activity in protein glycation 
[Tarwadi and Agte 2011]. Aminoguanidine (1.0 mM) and Trolox (2.5 mM) were used as 
positive controls for the assessment of potential anti-glycating effects of green tea 
catechins (flavanols) as outstanding representatives of flavonoids. 
Flavonoids show many biological and pharmacological activities including anti-
glycating properties. Inhibitory effects of several flavonoids on different glycating 
systems in the in vitro models have been already described (Table 6). The results 
obtained by flurescence measurement of the extent of total fluorescent AGEs 
formation revealed that the most pronounced inhibitory effect against MGO-mediated 
glycation of HSA possessed the galloylated GTCs (ECg and EGCg) predominantly at 
higher GTCs concentrations (0.025 mM and 0.050 mM). ECg showed a slightly higher 
anti-glycating effect than EGCg but it was not statistically significant. Inhibitory effects 
of several flavonoids including GTCs (0.10 mM) on methylgyloxal-mediated glycation of 
BSA have been investigated by Wu and Yen [2005]. It was noticed that the galloylated 
GTCs (ECg and EGCg) were more effective anti-glycating agents than the non-
galoylated GTCs (EC and EGC), which is in good agreement with our results. However, 
the most pronounced anti-glycating effect was described for EGCg (about 69%). Only 
the galloylated GTCs (ECg and EGCg) at the highest concentration (0.050 mM) caused 
obvious inhibitory effect on argpyrimidine generation during MGO-mediated glycation 
of HSA. ECg and EGCg were more effective anti-glycating agents than Trolox (2.5 mM) 
but less effective than aminoguanidine (1.0 mM). It can be concluded that the 
presence of the galloyl moiety in GTCs seems to be an important structural feature for 
their anti-glycating activities. It suggests that the binding affinity of GTCs may 
contribute to their anti-glycating properties [Kusuda et al. 2006, Wu and Yen 2005]. 
Also anti-glycating effects of green tea (Camellia sinensis, Theaceae) on glycation of 
BSA by different glycating agents glucose, fructose, and methylglyoxal) have been 




Anti-glycating activity of GTCs, especially EGCg, has been attributed to their 
trapping ability of reactive oxygen [Lunceford and Gugliucci 2005] and dicarbonyl 
species (e.g. GO and MGO) [Lo et al. 2006, Sang et al. 2007]. However, some other 
mechanisms such as chelating of transition metals or interaction with proteins can take 
place [Gugliucci et al. 2009]. Therefore, the mechanisms of actions of plant 
polyphenols including flavonoids need to be more elucidated. It is very important to 
note that the use of fluorescence methods for evaluation of protein glycation is limited 
by its imprecision. The measurement of total or some well-identified AGEs (e.g. 
argpyrimidine and CML) by techniques such as ELISA or HPLC could give more precise 
information on this matter.  
 
5.5 EFFECT OF METHYLGLYOXAL ON STRUCTURAL AND CATALYTIC PROPERTIES OF 
GST 
In this study, the effect of MGO on structural and catalytic properties of 
recombinant cytosolic GST from Schistosoma japonicum was investigated. This enzyme 
shares striking sequence homology, the characteristics of the amino acid residues in 
the G-site, and a common GSH-binding mode with mammalian mu-class GSTs [Ji et al. 
1997, Lim et al. 1994]. Glutathione metabolism and GST distribution in the tissues of 
diabetics may be crucial in the etiology, pathology, and prevention of diabetes [Raza et 
al. 2004]. Furthermore, the long-term hyperglycemia results in the decrease of GST 
enzymatic activity in tissues of diabetic animals [Lapshina et al. 2006, Petlevski et al. 
2003, Saito-Yamanaka et al. 1993, Thomas et al. 1989]. Administration of MGO to 
Swiss albino mice reduced GSH content and inhibited catalytic activity of several 
enzymes including GST, superoxide dismutase, glyoxalase I and II, and catalase 
[Choudhary et al. 1997]. All these findings indicate that ongoing diabetes may modify 
the detoxification metabolism. They also suggest that GST may be modified by non-
enzymatic glycation in vivo, and hence, provide a rationale of this enzyme use for 
studying glycation reactions. Reactive α-dicarbonyls (e.g. GO, MGO, 3-DG) are 
important precursors in the formation of AGEs in vivo. These compounds are far more 
reactive than the parent sugars (e.g. glucose) concerning their abilities to form inter- 
and intramolecular protein cross-links [Matsumoto et al. 2000, Kang 2006]. MGO is 
mainly generated not only by the fragmentation of triosephosphates, but also by the 
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catabolism of ketone bodies and threonine and the degradation of glucose-modified 
proteins in vivo. MGO has been identified as an intermediate in non-enzymatic 
glycation, and increased levels of MGO have been reported in patients suffering from 
diabetes mellitus [West 2000]. 
 
5.5.1 Effect of MGO-mediated glycation on GST catalytic activity 
Enzymatic activity of control sample (GST alone) was stable throughout the 
experiment. Methylglyoxal caused an irreversible decrease in enzymatic activity of GST 
(Figure 28). When GST was incubated with MGO (0.5, 1.0, and 2.0 mM) up to 180 min 
at 37°C its activity decreased by 12.1, 20.3, and 27.6%, respectively. The rate of 




Figure 28: Effect of glycation by MGO on GST catalytic activity. [GST] = 0.025 mg/ml 
and [MGO] = 0 - 2 mM. Samples were incubated for 180 min at pH 7.4 and 37°C. 
Catalytic activity of GST was expressed as percentage of control sample activity at all 
time intervals, which was 100% ± SD (%). Every point represents an average of two 
independent experiments, in which assays were performed in hexaplicates (*p < 0.05, 
Student’s t-test). 
 
It can be concluded that the incubation of GST with MGO led to the inhibition of 
its catalytic activity, which is probably caused by the lysine residues modification and 
the intramolecular cross-links formation induced by AGEs (further discuss below). This 




5.5.2 Effect of MGO-mediated glycation on primary amine content in GST 
Protein glycation, the chemical modification of primary amines (i.e. ε-amino group 
of lysine residues and α-amino group of N-terminal amino acids), leads to the decrease 
in amine content. Incubation of GST with all concentrations of MGO led to the gradual 
reduction in amine content (Table 17).  
 
Table 17: Amine content and number of primary amino groups after incubation (pH 
7.4, 37°C, and 7 days). 
 
Sample Amine content 
[mol NH2/mol GST] 
Number of primary 
amino groups 
GST 52.76 ± 1.17a 44 
GST + MGO (0.5 mM) 46.19 ± 2.68b 39 
GST + MGO (1.0 mM) 40.70 ± 1.22c 34 
GST + MGO (2.0 mM) 36.44 ± 1.42d 30 
Groups with different letters are significantly different (p < 0.01, Student´s t-test). 
 
 
Incubation of GST with MGO (0.5, 1.0, and 2.0 mM) for 7 days caused 12.5%, 
22.9%, and 30.9% decrease in amine content due to chemical modification of primary 
amines, respectively. GST in its native dimeric form contains 44 primary amino groups, 
suggesting that about 5, 10, and 14 amino groups were modified during its 7-day 
incubation with increasing concentration of MGO. 
MGO chemically modified GST by a process with the generally accepted features 
of glycation as evidenced by a decrease in amine content. Lysine and arginine residues 
are target sites for reducing sugars as well as MGO modification via the Maillard 
reaction [Seidler and Kowalewski 2003]. Typical arising products of MGO-mediated 
glycation of lysine and arginine residues are CEL, MOLD, argpyrimidine, and three 
structural isomers of hydroimidazolone.  All of these compounds were described and 
quantified in vivo [Thornalley 1996]. The GST dimer contains 44 lysine and 20 arginine 
residues with four Lys–Lys and two Lys–Arg sequence pairs, which are possible targets 
for glycating agents. Approximately 10 Lys residues per GST molecule were irreversibly 




5.5.3 AGEs formation and conformational changes of GST induced by MGO 
Incubation of GST with MGO led to the increase in fluorescence intensity due to 
the formation of non-specific AGEs with fluorescent properties (Figure 29) and the 
decrease in tryptophan fluorescence (Figure 30). The 7-day incubation of GST with 
MGO (0.5, 1.0, and 2.0 mM) at 37 °C caused an increase in AGEs formation by 32.0, 
55.1, and 85.3% and a decrease in tryptophan fluorescence by 11.3, 16.6, and 27.7% 
compared with the control sample (GST alone), respectively. 
 
Figure 29:  Effect of glycating agents on the formation of fluorescent AGEs.  
[GST] = 0.5 mg/ml, [MGO] = 0 - 2.0 mM, pH 7.4, 37 °C, 7 days of incubation, λex = 370 
nm, and λem = 440 nm. Every point represents an average of two independent 
experiments (six samples). Groups with different letters are significantly different (p < 
0.01, Student’s t-test). 
 
 
Figure 30:  Effect of glycating agents on the tryptophan fluorescence.  
[GST] = 0.5 mg/ml, [MGO] = 0 - 2.0 mM, pH 7.4, 37 °C, 7 days of incubation, λex = 295 
nm, and λem = 386 nm. Every point represents an average of two independent 
experiments (six samples). Groups with different letters are significantly different (p < 




In order to determine whether the changes in tryptophan fluorescence observed 
in the samples containing various concentrations of MGO (0 - 2.0 mM) correlated with 
the loss of primary amino groups in these samples, the fluorescence intensity was 
plotted as a function of amine content. The decrease in fluorescence emission (λex/λem 
= 295/386 nm) varied directly with the loss of primary amino groups (R = 0.987, p < 
0.013, Figure 31A). Changes in tryptophan fluorescence also correlated well with the 
formation of fluorescent AGEs (R = 0.997, p < 0.003, Figure 31B). In addition, the amine 
content was plotted as a function of AGEs fluorescence (Figure 31C), indicating that 
MGO-induced formation of AGEs was directly proportional to an irreversible loss of 




Figure 31: Correlations between amine content, tryptophan fluorescence, and 
formation of fluorescent AGEs in the samples containing GST and various 
concentrations of MGO. MGO-induced decrease in tryptophan fluorescence intensity 
correlated with the loss of primary amino groups (A) (R = 0.987, p < 0.013). Correlation 
between the decrease in tryptophan fluorescence and formation of AGEs (B) (R = 
0.997, p < 0.003). Plot of an increase in AGEs formation as a function of amine content 




The glycation-induced conformational changes in protein topography and 
modification of lysine residues, which may play a role in the enzyme catalysis (e.g. Lys-
44 is involved in the formation of G-site), probably contribute to enzyme inhibition 
(Figure 29). Also the formation of intramolecular cross-links induced by AGEs (Figure 
33) may be accompanied by progressive localized compaction of protein molecule that 
may result in its dysfunction (e.g. creation of surface to interior channels, impairment 
of conformational transition, and inhibition of domain movement during catalysis). 
Moreover, introducing AGEs, which are hydrophobic, would also promote a local 
condensation of substructures [Ulrich and Cerami 2001, Seidler 2005].  
 
5.5.4 Effect of MGO-mediated glycation on molecular charge of GST 
Native PAGE was used to investigate the changes in the molecular charge of GST 
due to glycation process by MGO. The results were expressed as a rise in percentage 
mobility of samples compared to the native protein (control). Native PAGE was run 
three times and the obtained mean values of protein relative mobility are presented in 
Table 18. Incubation of GST with MGO in all tested concentrations caused significantly 
increased mobility of the sample towards the positive electrode (Figure 32). This 
phenomenon was noticeable since the first day of incubation and the electrophoretic 
mobility of GST was gradually increased with increasing concentration of MGO. After 





Table 18: Effect of MGO-mediated glycation on molecular charge of GST. 
 
Sample Relative mobility (%) 
day 0 day 1 day 3 day 7 day 14 
GST 100.0 100.0 100.0 100.0 100.0 
GST + MGO (0.5 mM) 99.8 106.1 113.9 116.2 117.4 
GST + MGO (1.0 mM) 99.5 109.1 115.5 118.9 121.7 
GST + MGO (2.0 mM) 99.3 111.6 116.8 121.9 122.6 
Standard deviations (mean value of three independent experiments) were lower than 4.1%. Relative 






Figure 32: Effect of MGO-mediated glycation on molecular charge of GST.  
GST (0.5 mg/ml) was incubated with or without MGO (0 – 2 mM) in sodium phosphate 
buffer (0.1 M, pH 7.4) at 37°C for 14 days and then subjected to native PAGE. Proteins 
were visualized by Coomassie Blue G250. Electrophoretic mobilities were expressed as 
a rise in percentage mobility compared to the native protein (control). 
 
 
MGO-induced chemical modifications led to a change in molecular charge of 
GST, which became more anionic as revealed by native PAGE. These results indicate 
the progressive loss of the positive charge in the glycation modified GST molecule, 
which is caused by the irreversible modification of arginine and lysine residues [Kang 
2006, Nagai et al. 2000] as was confirmed by determination of amine content. MGO 
proved to be potent and fast-acting glycating agent because it progressively modified 
molecular charge of GST within the first 3 days of incubation.  
 
 
5.5.5 Protein cross-linking and aggregation 
Western blotting with specific antibody against advanced glycation end products 
and against AGEs derived from MGO (anti-MGO [3C]) was employed to confirm the 
formation of protein aggregates as a result of glycating agent’s activity. The presence 
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of high molecular protein cross-links in samples containing GST and MGO was 
observed using the both antibodies. These protein aggregates had molecular weight 
about 50 and 75 kDa (Figure 33A) corresponding to GST dimer and trimer, respectively. 
Also cleavage to shorter peptides (≈ 14 kDa) occurred in immunoblots that were 
incubated with anti-MGO primary antibody. Membranes were then stained with 
Ponceau S and changes in the migration of the main GST band (26 kDa) towards higher 
molecular weight and loss of its intensity was observed in all the samples containing 
MGO (Figure 33B). These results suggest that glycation by MGO was accompanied 
mainly by cross-linking, formation of high molecular protein aggregates containing 




Figure 33: Western blotting of GST samples treated with MGO. GST (0.5 mg/ml) was 
incubated with or without MGO (0 - 2 mM) in sodium phosphate buffer (0.1 M, pH 7.4) 
at 37°C for 11 days and then subjected to SDS PAGE with subsequent western blotting. 
Blot was reacted with rabbit anti-AGE primary antibody. Molecular weight standard 
(MM) and protein bands were marked by goat anti-rabbit IgG using a 
chemiluminescent detection with an alkaline phosphatase substrate (a). Membrane 




The SDS PAGE and subsequent western blotting clearly showed formation of 
protein cross-links with higher molecular weight (75 kDa) than native enzyme in the 
samples containing MGO. Also, the migration of the main protein band towards higher 
molecular weight was observed in all the samples containing MGO after 11 days of 
incubation. These results suggest that glycation by MGO was accompanied by cross-
linking and formation of high molecular protein aggregates containing AGEs. Such 
glycation modified sites on proteins act as trapping agents that bind transition metals 
and proteins, which may provide a nucleation center for extracellular plaque or 
intracellular inclusion body formation [Seidler 2005]. Protein aggregation takes part in 
the development and progress of various diseases including cataract [Argirova and 




Plant polyphenols are naturally occurring substances with a wide range of 
biological and pharmacological properties, which constitute a significant part of the 
human diet. They are readily able to react with various proteins including serum 
albumin which acts as a carrier of various endogenous and exogenous low molecular 
compounds in blood stream. One of the main goals of this thesis was to study 
structure-binding affinity relationships between serum albumin and two selected 
groups of polyphenolic compounds such as hydroxycinnamic acids and catechins 
(flavanols) in the in vitro models using spectroscopic (UV-Vis absorption and 
fluorescence spectroscopy) and electrophoretic (native and SDS PAGE) methods. 
Apart from rosmarinic acid, all tested HCAs quenched tryptophan fluorescence of 
BSA in the studied range of concentrations mainly by static quenching mechanism and 
thus showed the formation of non-fluorescent HCA-BSA complexes. The obtained 
results suggest that the binding affinity and number of binding sites of HCA-BSA 
systems depended on the size and structure of HCA and on the number and position of 
hydroxyls in the molecule of HCA. Their binding affinity towards BSA increased with 
increasing number of hydroxyls in their molecules. Coumaric acids containing only one 
hydroxyl showed the lowest binding affinity. Substitution of hydroxyl by methoxyl 
group lowered the binding affinity, whereas esterification of carboxyl group with 
quinic acid increased this ability. It was shown that one molecule of BSA associated 
with one molecule of HCA and all HCA-BSA interactions were spontaneous processes.  
All studied catechins quenched tryptophan fluorescence of HSA in the studied 
range of concentrations mainly by static quenching mechanism and thus the non-
fluorescent catechin-HSA complexes were formed. The complex formation for the 
galloylated catechins and HSA was confirmed also by UV-Vis absorption spectroscopy. 
All catechins bound spontaneously to the molecule of HSA with different binding 
affinity. The most important structural features of the studied catechins contributing 
to HSA binding were the galloyl group on the C-ring, followed by the number of 
hydroxyl groups on the B-ring, and the spatial arrangement (cis- and trans-structure). 
The number of binding sites was roughly one for all systems suggesting that one 
molecule of HSA associated with one molecule of catechin. The non-radiation energy 
transfer from HSA to all studied catechins was also occurred. The galloylated catechins 
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increased the electrophoretic mobility of HSA while the ability of aggregation and 
cross-linking of the tested catechins was not proved. 
Results imply that the studied plant polyphenols can be stored and transported in 
blood by serum albumin which may influence their biological and pharmacological 
activities. On the other hand, physiological functions of this protein could be altered by 
ligand binding. 
Green tea catechins (EC, EGC, ECg, and EGCg) were selected as representatives of 
the most outstanding plant polyphenols. Effects of GTCs on catalytic and structural 
properties of ERp57 enzyme have been investigated using fluorescence methods. The 
presence of galloyl moiety in the molecules of GTCs was an important structural 
feature which significantly contributed to the binding affinity of GTCs to ERp57 and 
evoked the protein conformational changes. By contrast, the number of hydroxyl 
groups in GTCs did not seem to play any role in their binding capability to ERp57. The 
GTCs except epicatechin were able to inhibit disulfide reductase activity of the protein. 
Their inhibitory activities were probably related to their binding affinity to the protein. 
Effects of green tea catechins on methylglyoxal-mediated non-enzymatic glycation 
of HSA in the in vitro models have been investigated by fluorescence methods and 
their structure-activity relationships were discussed. It can be concluded that the 
galloylated GTCs, namely epicatechin gallate and epigallocatechin gallate, were able to 
partially inhibit methylglyoxal-induced modification of HSA and thus prevent their 
deleterious action in the human organism. It was probably due to their antioxidant and 
chelating activities. However, other mechanisms may be take place. 
Finally, effects of methylglyoxal as a very potent glycating agent on structural and 
catalytic properties of recombinant cytosolic glutathion S-transferase from S. 
japonicum have been investigated in the in vitro model using spectroscopic (UV-Vis 
absorption and fluorescence spectroscopy) and electrophoretic (native PAGE, SDS 
PAGE/western blotting) methods. Methylglyoxal has proved to be the potent glycating 
agent, which caused concentration-dependent inhibition of GST catalytic activity, 
decrease in amine content of GST, enzyme conformational changes, generation of 
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Plant polyphenolic compounds naturally occurring in human diet possess a wide 
range of biological and pharmacological properties. They can interact with various 
proteins including enzymes. Their interaction with serum albumin has a great 
significance because of its ability to bind, transport and store many endogenous and 
exogenous low-molecular compounds present in blood circulation. One of the 
objectives of this thesis was to study chemical structure-binding affinity relationships 
of two important groups of polyphenolic substances, namely hydroxycinnamic acids 
and catechins (flavanols), with the molecule of serum albumin in the in vitro models 
using spectroscopic (UV-Vis absorption spectroscopy, fluorescence quenching method) 
and electrophoretic (native and SDS PAGE) methods. Some polyphenols caused the 
changes in protein conformation and the relationships between their structures and 
obtained binding affinities to serum albumin were noticed. 
Green tea catechins (flavanols) represent one of the most important plant 
polyphenolic substances. Interaction between these compounds and ERp57 enzyme in 
the in vitro model has been studied by fluorescence quenching method. Effects of 
green tea catechins on disulfide reductase activity of ERp57 enzyme in the in vitro 
model was monitored by sensitive fluorescent assay using dieosin glutathione disulfide 
as a fluorescent probe. This probe displays low fluorescence at the excitation/emission 
wavelength of 520 nm/545 nm, respectively, which significantly increases on reduction 
of its disulfide bonds (i.e. the presence of ERp57). Relationships between structures of 
the studied catechins and their binding affinities or their inhibitory effects on 
reductase activity of ERp57 were discussed. 
Alpha-dicarbonyl compounds (e.g. methylglyoxal) are formed during various 
metabolic processes and also by non-enzymatic protein glycation by glucose. They are 
thought to be principal precursors in generation of AGEs in vivo. Methylglyoxal can 
readily react with amino groups of proteins to form covalent cross-links and reactive 
oxygen species (ROS). It contributes to the onset and progression of many human 
diseases including diabetes mellitus and its related complications. Plant polyphenolic 
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compounds can reduce formation of AGEs and thus slow down the process of non-
enzymatic glycation by different mechanisms such as trapping of reactive α-dicarbonyl 
compounds or ROS. Another aim of this thesis was to study the effects of green tea 
catechins on methylglyoxal-mediated non-enzymatic glycation of serum albumin in the 
in vitro models using fluorescence methods for determination of total (“non-specific”) 
AGEs (λex/λem = 330/410 nm) and argpyrimidine as specific AGE (λex/λem = 320/380 
nm). Antiglycating activity of the studied catechins was dependent on their structure 
and concentration. 
Glutathione S-transferases (GSTs) represent a group of enzymes which catalyze 
conjugation of reduced glutathione to various hydrophobic compounds. They are 
important enzymes in detoxification of various xenobiotics. Effect of methylglyoxal on 
the structural and catalytic properties of GST from Schistosoma japonicum was 
investigated in the in vitro model using spectroscopic (UV-Vis absorption and 
fluorescence spectroscopy) and electrophoretic (native PAGE, SDS PAGE/western 
blotting) methods. It was found out that methylglyoxal reduced catalytic activity of GST 
and caused changes in the molecular charge of the enzyme as well as changes in its 
structure (i.e. conformational changes, formation of AGEs and cross-links) in 




Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové 
Katedra   Katedra biochemických věd 
Kandidát   Ing. Lucie Trnková 
Školitel   Prof. MUDr. Jaroslav Dršata, CSc. 
Název disertační práce Interakce proteinů s nízkomolekulárními látkami in vitro. 
Vliv glykace, látek přírodního původu a kombinace 
těchto faktorů na funkci a spektrální vlastnosti 
vybraných bílkovin. 
 
Rostlinné polyfenolické látky se přirozeně vyskytují v lidské stravě a vyznačují se 
řadou biologických a farmakologických vlastností. Mají schopnost reagovat s 
nejrůznějšími proteiny včetně enzymů. Velký význam má jejich interakce se sérovým 
albuminem, jehož jednou z nejvýznamnějších funkcí je vázání, přenos a ukládání řady 
endogenních a exogenních nízkomolekulárních látek v krevním řečišti. Jedním z cílů 
práce bylo prostudovat vztahy mezi chemickou strukturou a vazebnými afinitami dvou 
významných skupin polyfenolických látek, konkrétně hydroxyskořicových kyselin a 
katechinů (flavanolů), s molekulou sérového abuminu v in vitro modelech pomocí 
spektrálních (UV-Vis absorpční spektroskopie, metoda zhášení fluorescence) a 
elektroforetických (nativní a SDS PAGE) metod. Některé polyfenoly způsobily změny v 
konformaci proteinu a byly zaznamenány určité vztahy mezi jejich strukturou a 
zjištěnými vazebnými afinitami k sérovému albuminu. 
Mezi nejvýznamnější rostlinné polyfenolické látky patří katechiny (flavanoly) 
zeleného čaje. Byla studována možnost interakce těchto katechinů s enzymem ERp57 v 
in vitro modelu metodou zhášení fluorescence. Pro studování vlivu katechinů zeleného 
čaje na reduktasovou aktivitu enzymu ERp57 v in vitro modelu byla použita citlivá 
fluorescenční metoda využívající dieosinglutathiondisulfid jako fluorescenční sondu. 
Sonda vykazuje nízkou fluorescenci při vlnové délce excitace a emise 520 nm/545 nm, 
která významně vzroste po redukci disulfidové vazby, tedy v přítomnosti enzymu 
ERp57. Na základě získaných výsledků byl diskutován vztah mezi strukturou 
studovaných katechinů a jejich vazebnou afinitou, popř. jejich inhibičním účinkem na 
reduktasovou aktivitu ERp57. 
Alfa-dikarbonylové sloučeniny (např. methylglyoxal) vznikají během řady 
metabolických procesů a také neenzymovou glykací proteinů glukosou. Jsou 
považovány za důležité prekurzory vzniku AGEs in vivo. Methylglyoxal se snadno váže 
na aminoskupiny proteinů za tvorby kovalentních zesítěných agregátů (crosslinků) a 
reaktivních forem kyslíku (ROS). Tím přispívá ke vzniku a rozvoji různých onemocnění 
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včetně diabetu mellitu a jeho pozdních komplikací. Rostlinné polyfenolické látky 
mohou snižovat tvorbu AGEs a tím zpomalovat proces neenzymové glykace různými 
mechanismy, např. vychytáváním reaktivních α-dikarbonylových sloučenin nebo ROS. 
Dalším cílem práce bylo studium vlivu katechinů zeleného čaje na neenzymovou 
glykaci sérového albuminu zprostředkovanou methylglyoxalem v modelech in vitro 
pomocí fluorescenčních metod pro stanovení množství celkových (“nespecifických”) 
AGEs (λex/λem = 330/410 nm) a argpyrimidinu jako specifického AGE (λex/λem = 
320/380 nm). Antiglykační účinek studovaných katechinů závisel na jejich struktuře a 
koncentraci. 
Glutathion-S-transferasy (GSTs) představují skupinu enzymů, které katalyzují 
konjugaci redukovaného glutathionu s řadou hydrofobních látek. Jedná se o důležité 
enzymy v detoxikaci různých xenobiotik. V rámci této práce byl studován účinek 
methylglyoxalu na strukturní a katalytické vlastnosti rekombinantní cytosolické GST z 
Schistosoma japonicum v in vitro modelu pomocí spektroskopických (UV-Vis absorpční 
a fluorescenční spektroskopie) a elektroforetických (nativní PAGE, SDS PAGE/western 
blotting) metod. Bylo zjištěno, že methylglyoxal snižuje katalytickou aktivitu GST a 
způsobuje změny v náboji molekuly enzymu stejně tak jako změny v jeho struktuře (tj. 
změna konformace, tvorba AGEs a crosslinků) v závislosti na koncentraci. 
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